<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">NCP</journal-id>
<journal-id journal-id-type="hwp">spncp</journal-id>
<journal-id journal-id-type="nlm-ta">Nutr Clin Pract</journal-id>
<journal-title>Nutrition in Clinical Practice</journal-title>
<issn pub-type="ppub">0884-5336</issn>
<issn pub-type="epub">1941-2452</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0884533612452012</article-id>
<article-id pub-id-type="publisher-id">10.1177_0884533612452012</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Invited Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Microbiota and Its Metabolites in Colonic Mucosal Health and Cancer Risk</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Vipperla</surname><given-names>Kishore</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0884533612452012">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>O’Keefe</surname><given-names>Stephen J.</given-names></name>
<degrees>MD, MSc</degrees>
<xref ref-type="aff" rid="aff2-0884533612452012">2</xref>
</contrib>
</contrib-group>
<aff id="aff1-0884533612452012"><label>1</label>Division of General Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania</aff>
<aff id="aff2-0884533612452012"><label>2</label>Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania</aff>
<author-notes>
<corresp id="corresp1-0884533612452012">Stephen J. O’Keefe, MD, MSc, Professor of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh School of Medicine, 200 Lothrop Street, PUH, Mezzanine Level–C Wing, Pittsburgh, PA 15213, USA; e-mail: <email>sjokeefe@pitt.edu</email>.</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>10</month>
<year>2012</year>
</pub-date>
<volume>27</volume>
<issue>5</issue>
<issue-title>Nutrition and Cancer</issue-title>
<fpage>624</fpage>
<lpage>635</lpage>
<permissions>
<copyright-statement>© 2012 American Society for Parenteral and Enteral Nutrition</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">The American Society for Parenteral and Enteral Nutrition</copyright-holder>
</permissions>
<abstract>
<p>Recent advances in our ability to identify and characterize the human microbiota have transformed our appreciation of the function of the colon from an organ principally involved in the reabsorption of secretory fluids to a metabolic organ on a par with the liver. High-throughput technology has been applied to the identification of specific differences in microbial DNA, allowing the identification of trillions of microbes belonging to more than 1000 different species, with a metabolic mass of approximately 1.5 kg. The close proximity of these microbes with the mucosa and gut lymphoid tissue helps explain why a balanced microbiota is likely to preserve mucosal health, whereas an unbalanced composition, as seen in dysbiosis, may increase the prevalence of diseases not only of the mucosa but also within the body due to the strong interactions with the gut immune system, the largest immune organ of the body. Such abnormalities have been pinpointed as etiological factors in a wide range of diseases, including autoimmune disorders, allergy, irritable bowel syndrome, inflammatory bowel disease, obesity, and colon cancer. Recognition of the strong potential for food to manipulate microbiota composition has opened up new therapeutic strategies against these diseases based on dietary intervention.</p>
</abstract>
<kwd-group>
<kwd>colon</kwd>
<kwd>metagenome</kwd>
<kwd>fatty acids</kwd>
<kwd>inflammation</kwd>
<kwd>colonic neoplasms</kwd>
<kwd>irritable bowel syndrome</kwd>
<kwd>inflammatory bowel diseases</kwd>
<kwd>autoimmune diseases</kwd>
<kwd>allergy and immunology</kwd>
<kwd>obesity</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>A very diverse group of microorganisms comprising bacteria, archaea, viruses, and unicellular eukaryotes resides within our gastrointestinal tract. The bacterial concentration varies, with their number increasing from 10<sup>1</sup> colony-forming units (cfu)/mL in the stomach, 10<sup>3</sup> cfu/mL in the duodenum, 10<sup>4</sup> cfu/mL in the jejunum, 10<sup>7</sup> cfu/mL in the ileum, to the maximum of 10<sup>12</sup> cfu/mL in the colon, contributing to 60% of the fecal mass (<xref ref-type="fig" rid="fig1-0884533612452012">Figure 1</xref>).<sup><xref ref-type="bibr" rid="bibr1-0884533612452012">1</xref></sup> The bacteria primarily belong to 2 major phyla, gram-positive <italic>Firmicutes</italic> and gram-negative <italic>Bacteroidetes</italic>, with other phyla such as <italic>Proteobacteria, Actinobacteria, Fusobacteria, Verrucomicrobia</italic>, and <italic>Cyanobacteria</italic> in minor proportions.<sup><xref ref-type="bibr" rid="bibr2-0884533612452012">2</xref></sup> They collectively form a 100-trillion super colony with more than 800 species and 7000 strains identified. They form a vibrant mass of foreign DNA, outnumbering the host in cell number by 10:1 and in DNA content by 150:1, weighing approximately 1–2 kg.<sup><xref ref-type="bibr" rid="bibr3-0884533612452012">3</xref></sup> They are initially acquired when maternal microbiota is passed on during the birth, breastfeeding, maternal skin, and environmental contact.<sup><xref ref-type="bibr" rid="bibr4-0884533612452012">4</xref></sup> After significant changes during the first year, the gross composition and distribution of microbiota remain quite stable thereafter over the years but are influenced by several factors such as diet, environment, geography, medication, radiation, surgery, stress, and disease.<sup><xref ref-type="bibr" rid="bibr5-0884533612452012">5</xref>,<xref ref-type="bibr" rid="bibr6-0884533612452012">6</xref></sup></p>
<fig id="fig1-0884533612452012" position="float">
<label>Figure 1.</label>
<caption><p>Spatial and temporal aspects of intestinal microbiota composition. (A) Variations in microbial numbers and composition across the length of the gastrointestinal (GI) tract. (B) Longitudinal variations in microbial composition in the intestine. (C) Temporal aspects of microbiota establishment and maintenance and factors influencing microbial composition. From Sekirov I et al.7 Copyright © 2010. Reprinted with permission from The American Physiological Society.</p></caption>
<graphic xlink:href="10.1177_0884533612452012-fig1.tif"/>
</fig>
<p>Their sheer numbers, diversity, and strict anaerobic nature make the characterization and identification of up to 80% of microbiota impossible by culturing.<sup><xref ref-type="bibr" rid="bibr2-0884533612452012">2</xref></sup> In the present genomic era, culture-independent identification of these microbes by techniques such as high-throughput gene sequencing and polymerized chain reaction (PCR) of conserved regions of microbial 16S rRNA has expanded our understanding of their diversity and composition.<sup><xref ref-type="bibr" rid="bibr7-0884533612452012">7</xref></sup> Analysis of the genomic content of the gut microbiota by metagenomics, metabolic profiling, and studying the influence of diet, toxins, disease, and microbiota by metabonomics have cast light on the contributions of the microbial world within us.<sup><xref ref-type="bibr" rid="bibr8-0884533612452012">8</xref>,<xref ref-type="bibr" rid="bibr9-0884533612452012">9</xref></sup> Gnotobiology, the science of germ-free (GF) mice colonized with select microbial species to study their metabolic activities, has further helped us understand the host-microbe interaction in a simplified ecosystem.</p>
<p>Our lack of thorough understanding of the “core microbiota” to define “normal microbiota” hampers our ability to differentiate the “good” from the “bad” bacteria.<sup><xref ref-type="bibr" rid="bibr10-0884533612452012">10</xref></sup> The association alone of a particular microbiome with a disease does not necessarily imply the causality, so we have to be wary in interpreting these observations in speculating their role as causative agents of the disease. Innovative methods to influence the microbial composition and alter their metabolic behavior to benefit our health are areas of immense recent research interest.</p>
<sec id="section1-0884533612452012">
<title>Microbiota and the Host: Symbiosis and Dysbiosis</title>
<p>Although most ingested nutrients are digested along the gastrointestinal tract, a small percentage, mainly dietary fiber, resistant starch, and some protein, remains undigested. This represents the food for colonic microbiota that process these undigested material by fermentation to derive their own energy as well as produce metabolites that are key to the host energy homeostasis. The commensal bacteria prevent infections by enteric pathogenic organisms by competing for nutrition and producing bactericidal factors forming a “colonization resistance.”<sup><xref ref-type="bibr" rid="bibr11-0884533612452012">11</xref></sup> They assist host immune system regulation, process drug metabolites affecting their pharmacokinetics and adverse effect profile, and importantly synthesize vitamins such as biotin, folic acid, and vitamin K essential for the host, thereby representing an excellent example of symbiosis.<sup><xref ref-type="bibr" rid="bibr12-0884533612452012">12</xref></sup> The complexity of the physiological activities in the colon mediated by the microbiota makes it a metabolic organ in its own right.<sup><xref ref-type="bibr" rid="bibr13-0884533612452012">13</xref></sup> A variety of factors can disturb the composition, distribution, and metabolic activity of this ecosystem, resulting in a state of dysbiosis. These include antibiotics, psychological and physical stressors (a week of physical restraint at night resulted in a disturbed diversity of gut microbiota in a murine model and made them susceptible to infection when challenged by a murine enteric pathogen, <italic>Citrobacter rodentium</italic>), radiation, dysmotility (can cause bacterial overgrowth), surgery (Roux-en-Y gastric bypass operation resulted in higher concentrations of <italic>Proteobacteria</italic> [52-fold] and lower concentrations of <italic>Firmicutes</italic> [4.5-fold] and <italic>Bacteroidetes</italic> [2-fold] in comparison with sham-operated rats), and dietary changes (Western diet rich in red meat and fat promotes carcinogenic hydrogen sulfide–producing bacteria).<sup><xref ref-type="bibr" rid="bibr14-0884533612452012">14</xref><xref ref-type="bibr" rid="bibr15-0884533612452012"/><xref ref-type="bibr" rid="bibr16-0884533612452012"/><xref ref-type="bibr" rid="bibr17-0884533612452012"/>-<xref ref-type="bibr" rid="bibr18-0884533612452012">18</xref></sup></p>
<p>The microbiota ferments undigested carbohydrate residues preferentially in the proximal colon, yielding short-chain fatty acids (SCFAs) and gases hydrogen and methane. The undigested protein residues are fermented more distally, yielding branched SCFAs, hydrogen sulfide, ammonia, and several phenolic and indolic compounds.<sup><xref ref-type="bibr" rid="bibr19-0884533612452012">19</xref>,<xref ref-type="bibr" rid="bibr20-0884533612452012">20</xref></sup> The major SCFAs produced are acetate, propionate, and butyrate in the ratio of 60:25:15.<sup><xref ref-type="bibr" rid="bibr21-0884533612452012">21</xref></sup> Other bacterial end products in minor proportions include lactate, ethanol, and other SCFAs (succinate, formate, valerate, caproate, isobutyrate, 2-methyl-butyrate, and isovalerate).<sup><xref ref-type="bibr" rid="bibr22-0884533612452012">22</xref></sup> The emerging field of metabolomics is revealing a vast array of microbial metabolites whose functions remain to be discovered.</p>
<p>SCFAs are significant sources of energy, contributing up to 10% of the daily calorie requirement in health, and may provide up to 1000 kcal/d in patients with short bowel syndrome where caloric salvage may permit survival.<sup><xref ref-type="bibr" rid="bibr23-0884533612452012">23</xref></sup> SCFAs lower the pH of the intracolonic milieu, which prevents the growth of pH-sensitive pathogenic bacteria, inhibits the degradation of primary bile acids to the carcinogenic secondary bile acids, and decreases the solubility of free bile acids, making them even less carcinogenic.<sup><xref ref-type="bibr" rid="bibr24-0884533612452012">24</xref></sup> The increasingly available free calcium in an acidic environment also binds to the free bile acids and fatty acids.<sup><xref ref-type="bibr" rid="bibr25-0884533612452012">25</xref></sup> There is evidence indicating that butyrate reinforces the colonic defense barrier by inducing the secretion of mucins, trefoil factors, and antimicrobial peptides.<sup><xref ref-type="bibr" rid="bibr26-0884533612452012">26</xref></sup> SCFAs have distinct anti-inflammatory activities due to their regulation of prostaglandin E2, cytokine, and chemokine release from human immune cells.<sup><xref ref-type="bibr" rid="bibr27-0884533612452012">27</xref></sup> They were also shown to enhance intestinal adaptation in short bowel syndrome, possibly mediated via glucagon-like peptide (GLP)–2.<sup><xref ref-type="bibr" rid="bibr28-0884533612452012">28</xref></sup></p>
<p>The roles of the 3 major SCFAs in our metabolism have been summarized in <xref ref-type="table" rid="table1-0884533612452012">Table 1</xref>. Although most members of the microbiota are associated with the fermentation process, <italic>Clostridia</italic> clusters XIVa and IV of <italic>Firmicutes</italic> are considered the chief butyrate producers.<sup><xref ref-type="bibr" rid="bibr29-0884533612452012">29</xref></sup> Butyrate is the main energy source for colonic epithelial cells, being preferred over circulatory glucose or glutamine, and up to 90% of it is metabolized by colonocytes.<sup><xref ref-type="bibr" rid="bibr30-0884533612452012">30</xref></sup> It acts as the chief regulator of epithelial growth by inducing proliferation of normal epithelial cells and enhancing differentiation. It suppresses inflammatory mediators such as tumor necrosis factor–α (TNF-α) and nitric oxide, potentiates p53 gene expression and transforming growth factor–β (TGF-β) signaling and its tumor-suppressing activity, and increases the immunogenicity of cancer cells.<sup><xref ref-type="bibr" rid="bibr31-0884533612452012">31</xref><xref ref-type="bibr" rid="bibr32-0884533612452012"/><xref ref-type="bibr" rid="bibr33-0884533612452012"/>-<xref ref-type="bibr" rid="bibr34-0884533612452012">34</xref></sup> Butyrate activates the apoptosis cascade and induces growth arrest of tumors by histone hyperacetylation and exerts immunomodulatory effects by suppressing nuclear factor–κB (NF-κB) activation, a transcription factor controlling the expression of genes encoding proinflammatory responses.<sup><xref ref-type="bibr" rid="bibr35-0884533612452012">35</xref><xref ref-type="bibr" rid="bibr36-0884533612452012"/>-<xref ref-type="bibr" rid="bibr37-0884533612452012">37</xref></sup> Butyrate’s anticarcinogenic properties have also been attributed to its enhancement of the detoxifying enzyme glutathione-S-transferase activity, as well as inhibition of tumor cell migration and tumor-induced angiogenesis.<sup><xref ref-type="bibr" rid="bibr38-0884533612452012">38</xref><xref ref-type="bibr" rid="bibr39-0884533612452012"/>-<xref ref-type="bibr" rid="bibr40-0884533612452012">40</xref></sup> It is also proposed to play a role in inducing satiety by modulating gut peptides.<sup><xref ref-type="bibr" rid="bibr41-0884533612452012">41</xref>,<xref ref-type="bibr" rid="bibr42-0884533612452012">42</xref></sup></p>
<table-wrap id="table1-0884533612452012" position="float">
<label>Table 1.</label>
<caption><p>The Major Short-Chain Fatty Acids (SCFAs): Their Principle Actions and Mechanisms</p></caption>
<graphic alternate-form-of="table1-0884533612452012" xlink:href="10.1177_0884533612452012-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">SCFA</th>
<th align="center">Site of Action</th>
<th align="center">Principle Actions/Effects and Proposed Mechanisms</th>
</tr>
</thead>
<tbody>
<tr>
<td>Propionic acid</td>
<td>Adipose tissue and liver</td>
<td><bold><italic>Metabolism</italic>:</bold> primary substrate for gluconeogenesis (especially in ruminants), inhibits HMG-CoA → decreased hepatic cholesterol synthesis</td>
</tr>
<tr>
<td/>
<td/>
<td><bold><italic>Anti-inflammatory</italic>:</bold> downmodulates intestinal cyclooxygenase activity; stimulates GPCR41 and GPCR43; inhibits NF-κB through PPARγ</td>
</tr>
<tr>
<td/>
<td/>
<td><bold><italic>Antimicrobial</italic>:</bold> inhibits expression of the genes facilitating invasion and penetration of the intestinal epithelium by <italic>Salmonella typhimurium</italic></td>
</tr>
<tr>
<td/>
<td/>
<td><bold><italic>Improvement of insulin sensitivity</italic>:</bold> inhibits lipolysis and promotes lipogenesis in VAT and suppresses FA production in liver → lower FA levels in liver and plasma → lower inflammatory state → mitigates the insulin resistance caused by FA-inflammation interplay</td>
</tr>
<tr>
<td/>
<td/>
<td><bold><italic>Satiety</italic>:</bold> promotes satiety via complex neuronal, endocrine, paracrine, and autocrine pathways; influences the production of adipokinetic hormones, such as leptin, a potent anorexigenic hormone</td>
</tr>
<tr>
<td>Butyric acid</td>
<td>Colonocyte</td>
<td><bold><italic>Anticarcinogenic</italic>:</bold> inhibits HDAC → hyperacetylation of histones and enhancement of the accessibility of transcription factors to nucleosomal DNA → regulates gene expression and cell function; enhances the activity of the detoxifying enzyme glutathione-S-transferase, inhibits tumor cell migration by inhibiting DAF expression and pro-metastatic metalloproteinase activation; inhibits tumor-induced angiogenesis through modulation of angiogenesis-related proteins, VEGF and HIF-1α</td>
</tr>
<tr>
<td/>
<td/>
<td><bold><italic>Anti-inflammatory</italic>:</bold> suppresses NF-κB activation through the inhibition of HDAC, inhibition of the interferon-γ production and/or signaling, and the upregulation of PPARγ; acts as a signaling molecule through GPR41 and GPR43</td>
</tr>
<tr>
<td/>
<td/>
<td><bold><italic>Reinforcement of colonic defense barrier</italic>:</bold> increases MUC2 gene expression → stimulates mucin synthesis; enhances intestinal trefoil factor (ITF or TFF3) secretion by the intestinal goblet cells</td>
</tr>
<tr>
<td/>
<td/>
<td><bold><italic>Satiety</italic>:</bold> via ? GLP-1 or peptide YY</td>
</tr>
<tr>
<td>Acetic acid</td>
<td>Liver, muscle, and other peripheral tissues</td>
<td><bold><italic>Metabolism</italic>:</bold> primary substrate for cholesterol synthesis</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0884533612452012">
<p>DAF, decay accelerating factor; FA, fatty acid; GLP-1, glucagon-like peptide 1; GPCR, G-protein–coupled receptor; HDAC, histone deacetylase; HIF-1α, hypoxia-inducible factor α; NF-κB, nuclear factor–κB; PPARγ, peroxisome proliferator-activated receptor γ; VAT, visceral adipose tissue; VEGF, vascular endothelial growth factor.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Acetate is produced in such large quantities that it is incompletely metabolized and mostly absorbed into the bloodstream.<sup><xref ref-type="bibr" rid="bibr43-0884533612452012">43</xref></sup> It is the primary substrate for acetyl-CoA synthetase-mediated cholesterol synthesis in the adipose tissue, mammary glands, and liver, hence affecting host lipid metabolism.<sup><xref ref-type="bibr" rid="bibr44-0884533612452012">44</xref></sup> Propionate is also mostly taken up by the liver and is used as substrate for gluconeogenesis. It also inhibits hepatic cholesterol synthesis by inhibiting 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) synthase and HMG-CoA reductase.<sup><xref ref-type="bibr" rid="bibr45-0884533612452012">45</xref>,<xref ref-type="bibr" rid="bibr46-0884533612452012">46</xref></sup> High production rates of propionic acid lower the plasma fatty acid levels by inhibiting lipolysis, inducing lipogenesis in adipose tissue and decreasing fatty acid synthesis in the liver, resulting in decreased fatty acid–related inflammation and improved insulin sensitivity.<sup><xref ref-type="bibr" rid="bibr47-0884533612452012">47</xref></sup> Propionate exhibits anti-inflammatory properties by downmodulating intestinal cyclooxygenase activity and inhibiting NF-κB.<sup><xref ref-type="bibr" rid="bibr48-0884533612452012">48</xref>,<xref ref-type="bibr" rid="bibr49-0884533612452012">49</xref></sup> It displays antimicrobial activity by inhibiting expression of the genes facilitating invasion and penetration of the intestinal epithelium by <italic>Salmonella typhimurium</italic>.<sup><xref ref-type="bibr" rid="bibr50-0884533612452012">50</xref></sup> It promotes satiety via complex neuronal, endocrine, paracrine, and autocrine pathways and influences the production of adipokinetic hormones, such as leptin, a potent anorexigenic hormone.<sup><xref ref-type="bibr" rid="bibr51-0884533612452012">51</xref>,<xref ref-type="bibr" rid="bibr52-0884533612452012">52</xref></sup></p>
<p>The indigenous microbiota plays an essential role in the development and education of the immune system.<sup><xref ref-type="bibr" rid="bibr53-0884533612452012">53</xref></sup> Studies in GF mice revealed underdeveloped lymphatic systems, fewer Peyer’s patches, isolated lymphoid follicles, fewer intestinal dendritic cells, and poorly formed spleens. The intestinal epithelial cells act as an interface between the gut microbiota and the gut-associated lymphoid tissue (GALT).<sup><xref ref-type="bibr" rid="bibr54-0884533612452012">54</xref></sup> The pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs) on the epithelial cells play a key role in microbial recognition by binding to specific microbial macromolecules.<sup><xref ref-type="bibr" rid="bibr55-0884533612452012">55</xref></sup> TLR signaling via NF-κB pathways, mitogen-activated protein kinase, and caspase- dependent signaling promotes epithelial cell proliferation, secretion of IgA, and expression of antimicrobial peptides.<sup><xref ref-type="bibr" rid="bibr56-0884533612452012">56</xref></sup> Dysregulated cascade of these events can result in a state of unrestrained chronic inflammation and repair that may explain the role of the microbiota in chronic inflammation, inflammatory bowel disease (IBD), and colorectal carcinogenesis.</p>
</sec>
<sec id="section2-0884533612452012">
<title>Microbiota and Disease</title>
<p>The influence of gut microbiota and its metabolites is not confined to the intestine. Dysbiosis has been associated not only with the diseases of intestinal mucosa, such as IBD and colon cancer, but also with systemic disorders such as obesity, metabolic syndrome, allergy, autoimmune diseases, diabetes, and liver disease. The implications of dysbiosis are summarized in <xref ref-type="fig" rid="fig2-0884533612452012">Figure 2</xref>.</p>
<fig id="fig2-0884533612452012" position="float">
<label>Figure 2.</label>
<caption><p>Gut microbiota participate in the host metabolic homoeostasis, and a disturbed composition/metabolic activity, dysbiosis, is associated with several intestinal as well as systemic diseases. Angptl4, angiopoetin-related protein 4; APC, antigen-presenting cell; DM, diabetes; H2, hydrogen; H2S, hydrogen sulfide; IBD, inflammatory bowel disease; IBS, irritable bowel syndrome; IgA, immunoglobulin A; LPL, lipoprotein lipase; LPS, lipopolysaccharide; NAFLD, nonalcoholic fatty liver disease; PYY, pancreatic peptide YY; SCFA, short-chain fatty acids; Teff, effector T cell; TLR, Toll-like receptor; Treg, regulatory T cell.</p></caption>
<graphic xlink:href="10.1177_0884533612452012-fig2.tif"/>
</fig>
</sec>
<sec id="section3-0884533612452012">
<title>Colorectal Cancer</title>
<p>Colorectal cancer is the third most commonly diagnosed cancer and third most leading cause of cancer death in both men and women in the United States, with around 141,210 new cases and 49,380 deaths expected in 2011, as per an estimate by American Cancer Society. Epidemiological evidence derived from comparative population studies around the world supports the role of diet in CRC development, crediting the indigestible fiber/resistant starch, fruits and vegetables, antioxidants, calcium, and vitamin D with a protective effect and implicating high consumption of red meat and animal fat in increasing risk of colorectal cancer.<sup><xref ref-type="bibr" rid="bibr18-0884533612452012">18</xref></sup></p>
<p>Our hypothesis is that risk from diet is mediated by the microbiota.<sup><xref ref-type="bibr" rid="bibr12-0884533612452012">12</xref></sup> Dietary residues in the colon influence the composition of the colonic microbiota and their metabolites that regulate mucosal proliferation and therefore cancer risk. Thus, diets that generate large quantities of colonic carbohydrate residues (eg, high fiber and high complex carbohydrate) increase microbial fermentation and butyrate production and reduce risk, whereas diets rich in meat and fat stimulate sulfate-reducing bacteria (SRB) production of genotoxic hydrogen sulfide and microbial conversion of bile acids to carcinogenic secondary bile acids, thus increasing risk of colon cancer.<sup><xref ref-type="bibr" rid="bibr57-0884533612452012">57</xref></sup></p>
<p>Meat being a rich source of dietary sulfur (higher content of sulfur–amino acids) promotes the growth of SRB (eg, <italic>Desulfovibrio vulgaris</italic>), which outcompete methanogenic bacteria for hydrogen to form hydrogen sulfide, a highly toxic compound that impairs cytochrome oxidase, suppresses butyrate utilization, inhibits the synthesis of mucus, and promotes methylation of DNA, which is genotoxic via the generation of free radicals.<sup><xref ref-type="bibr" rid="bibr58-0884533612452012">58</xref>,<xref ref-type="bibr" rid="bibr59-0884533612452012">59</xref></sup> The H<sub>2</sub> gas, when produced in excess and not converted to methane (by hydrogenotrophic methanogens [eg, <italic>Methanobrevibacter smithii</italic>], as seen in low-risk rural Africans consuming high–complex carbohydrate diets), can damage the cells by impairing nicotinamide adenine dinucleotide (NAD) regeneration and inhibiting respiration.<sup><xref ref-type="bibr" rid="bibr60-0884533612452012">60</xref></sup></p>
<p>It has been established that a high-fat diet increases fecal bile acids by stimulating their synthesis and enterohepatic circulation. 7α-Dehydroxylating bacteria convert colonic primary bile acids to secondary bile acids, which are cytotoxic to colonic epithelial cells, mutagenic, and antiapoptotic in animal models.<sup><xref ref-type="bibr" rid="bibr61-0884533612452012">61</xref><xref ref-type="bibr" rid="bibr62-0884533612452012"/>-<xref ref-type="bibr" rid="bibr63-0884533612452012">63</xref></sup> In addition, hydrophobic bile acids have been shown to promote genomic instability and colorectal carcinogenesis by inducing micronuclei formation, mitotic perturbations, and decreases in spindle checkpoint proteins.<sup><xref ref-type="bibr" rid="bibr64-0884533612452012">64</xref></sup> In our recent study, we analyzed the colonic contents of secondary bile acids and SCFAs in African Americans, Caucasian Americans, and native Africans.<sup><xref ref-type="bibr" rid="bibr22-0884533612452012">22</xref></sup> We noted that dietary fat and total/animal protein intakes were higher in African Americans and Caucasian Americans when compared with native Africans. The amounts of lithocholic acid, deoxycholic acid, and cholic acid were all significantly higher in African Americans than native Africans, with no significant differences noted between the African Americans and Caucasian Americans (<xref ref-type="fig" rid="fig3-0884533612452012">Figure 3</xref>). In contrast, SCFA content was higher in native Africans compared with the other 2 groups, with the exception of the branched-chain fatty acid, 2-methylvalerate, a derivative of protein fermentation, which was significantly higher in the American groups (<xref ref-type="fig" rid="fig4-0884533612452012">Figure 4</xref>). These results corroborate our hypothesis that higher risk of colon cancer in Americans compared with the native Africans could be explained by their higher fat intake, which results in higher concentrations of carcinogenic secondary bile acids as a result of harmful bacteria, whereas the lower risk of cancer in the native Africans correlated with higher concentrations of beneficial SCFAs produced by good bacteria.</p>
<fig id="fig3-0884533612452012" position="float">
<label>Figure 3.</label>
<caption><p>Major bile acid contents in colonic evacuates were significantly lower in native Africans (NAs) compared with African Americans (AAs) and Caucasian Americans (CAs). *<italic>P</italic> &lt; .05 vs. NAs, Mann-Whitney testing. There was no difference between AAs and CAs. LCA data have been magnified 10 times to be visible on this scale. Bile acid abbreviations: CA, cholic acid; DCA, deoxycholic acid; LCA, lithocholic acid.</p></caption>
<graphic xlink:href="10.1177_0884533612452012-fig3.tif"/>
</fig>
<fig id="fig4-0884533612452012" position="float">
<label>Figure 4.</label>
<caption><p>Major short-chain fatty acid concentrations in stools (left) and in colonic evacuates (right, previously reported by O’Keefe et al12 ) were significantly higher in native Africans (NAs) compared with African Americans (AAs) and Caucasian Americans (CAs). *<italic>P</italic> &lt; .05 vs CA and AA; **<italic>P</italic> &lt; .001 vs CA and AA, Mann-Whitney testing. There were no significant differences between AAs and CAs. Adapted from O’Keefe et al12 and Ou et al.<sup><xref ref-type="bibr" rid="bibr22-0884533612452012">22</xref></sup> Reprinted with permission from Taylor &amp; Francis, <ext-link ext-link-type="uri" xlink:href="http://www.tandfonline.com">http://www.tandfonline.com</ext-link>; and the American Society for Nutrition.</p></caption>
<graphic xlink:href="10.1177_0884533612452012-fig4.tif"/>
</fig>
<p>However, the situation is far more complex, as not all people eating a high-meat, low-fiber diet get colon cancer, and net risk is determined by multiple interacting factors, including host genetic predisposition, host health, and luminal interactions. For example, many other microbiota disturbances have been associated with colon cancer risk and disease. In a study analyzing the stool samples of 20 patients with colorectal cancer and 17 healthy volunteers, patients with colorectal cancer demonstrated decreased levels of butyrate-producing <italic>Eubacterium rectale</italic> and <italic>Faecalibacterium prausnitzii</italic> and increased populations of <italic>Enterococcus faecalis</italic> when compared with healthy volunteers, suggesting a shift in the colonic bacterial population as a factor leading to colon cancer.<sup><xref ref-type="bibr" rid="bibr65-0884533612452012">65</xref></sup> In another, patients with colorectal cancer had significant elevation of the <italic>Bacteroides-Prevotella</italic> population.<sup><xref ref-type="bibr" rid="bibr66-0884533612452012">66</xref></sup> Most recently, a very high abundance of <italic>Fusobacterium nucleatum</italic>, an oral pathogen, usually responsible for periodontitis, was detected in the colorectal tumor tissue.<sup><xref ref-type="bibr" rid="bibr67-0884533612452012">67</xref></sup></p>
<p>Chronic infections resulting in mucosal hyperproliferation and cancer, in cases such as <italic>Helicobacter pylori</italic>–associated gastric mucosa-associated lymphoid tissue (MALT) lymphoma, supports the speculated role of a chronic inflammatory state induced by the microbiotal imbalance to be behind the cancer development.<sup><xref ref-type="bibr" rid="bibr68-0884533612452012">68</xref></sup> In a mice model, colonization of enterotoxigenic <italic>Bacteroides fragilis</italic>, a human colonic commensal bacterium known to cause inflammatory diarrhea, resulted in colitis and strongly induced colonic tumors.<sup><xref ref-type="bibr" rid="bibr69-0884533612452012">69</xref></sup> <italic>Streptococcus gallolyticus</italic> (formerly <italic>Streptococcus bovis</italic>) is classically associated with colon cancers, although a causative association has not been established.<sup><xref ref-type="bibr" rid="bibr70-0884533612452012">70</xref></sup> The increased risk of colon cancer in patients with ulcerative colitis and even higher risk when the colon is primarily affected point to the fact that inflammation in conjunction with the carcinogenic effects of the bacteria mediates the neoplastic process. C-reactive protein levels in the bloodstream are elevated and suppression of inflammation with aspirin is expected to reduce the risk of cancer development.<sup><xref ref-type="bibr" rid="bibr71-0884533612452012">71</xref>,<xref ref-type="bibr" rid="bibr72-0884533612452012">72</xref></sup> Swidsinski et al<sup><xref ref-type="bibr" rid="bibr73-0884533612452012">73</xref></sup> noted that adherent/invasive <italic>Escherichia coli</italic> strains colonized the colonic mucosa, intracellularly, in patients with colorectal carcinoma and adenoma but not in normal colonic mucosa.</p>
<p>Superoxide-producing <italic>E faecalis</italic> has been shown to cause epithelial DNA damage with carcinogenic consequences.<sup><xref ref-type="bibr" rid="bibr74-0884533612452012">74</xref></sup> Intestinal bacteria may also promote carcinogenesis by increasing the progression of chemically induced aberrant crypt foci.<sup><xref ref-type="bibr" rid="bibr75-0884533612452012">75</xref></sup> Finally, there is also substantial experimental evidence for the cytotoxicity and mutagenicity of heme.<sup><xref ref-type="bibr" rid="bibr76-0884533612452012">76</xref></sup> Burning meat by grilling or barbequing produces heterocyclic amines, which are potent experimental carcinogens.<sup><xref ref-type="bibr" rid="bibr76-0884533612452012">76</xref>,<xref ref-type="bibr" rid="bibr77-0884533612452012">77</xref></sup> The mutagenic effects of bile acids can be inhibited by increased butyrate production from high amylose-resistant maize starch, and the toxicity of heme can be annulled by chlorophyll.<sup><xref ref-type="bibr" rid="bibr78-0884533612452012">78</xref>,<xref ref-type="bibr" rid="bibr79-0884533612452012">79</xref></sup> The effects of dietary casein and meat on DNA damage can also be prevented by the simultaneous consumption of resistant starch.<sup><xref ref-type="bibr" rid="bibr80-0884533612452012">80</xref></sup> Lactobacilli can reduce the mutagenic properties of bile acids.</p>
<p>Thus, evidence is compelling that colon cancer risk is determined by interactions between the diet and the colonic microbiota, and it can therefore be mitigated by their modification.</p>
</sec>
<sec id="section4-0884533612452012">
<title><italic>Clostridium difficile</italic>–Associated Diarrhea</title>
<p>Diarrhea resulting from antibiotic usage is the result of an altered microbial diversity and decreased fecal SCFA production by butyrate-producing bacteria.<sup><xref ref-type="bibr" rid="bibr81-0884533612452012">81</xref></sup> <italic>Clostridium difficile</italic>–associated diarrhea has been a growing problem, with indiscriminate antibiotic usage resulting in microbial imbalance and overgrowth of toxigenic clostridial strains. In a murine model of <italic>C difficile</italic> infection (CDI), antibiotics were given to disrupt their intestinal colonization resistance followed by <italic>C difficile</italic> by oral gavage to induce CDI.<sup><xref ref-type="bibr" rid="bibr82-0884533612452012">82</xref></sup> Severe colitis was noted on histopathology in animals that became critically ill with less severe changes noted in those that did well clinically. 16S rRNA gene sequence analysis revealed a dominant <italic>Proteobacteria</italic> in the gut tissues of the critically ill group, whereas <italic>Firmicutes</italic> dominated the clinically well group, closely resembling that of an untreated animal group. Thus, severity of disease was felt to be a result of the interplay of clostridial proliferation and ecologic dynamics of indigenous microbiota in the wake of antibiotic use. Fecal bacteriotherapy, transplantation of normal bacterial flora from stool obtained from a healthy donor, has been shown to be remarkably successful in the treatment of chronic recurrent CDI, restoring the numbers of <italic>Firmicutes</italic> and <italic>Bacteroidetes</italic>.<sup><xref ref-type="bibr" rid="bibr83-0884533612452012">83</xref></sup></p>
</sec>
<sec id="section5-0884533612452012">
<title>Inflammatory Bowel Disease</title>
<p>Crohn’s disease and ulcerative colitis, the 2 distinct entities comprising IBD, are a significant health burden in the United States with more than 1.4 million cases.<sup><xref ref-type="bibr" rid="bibr84-0884533612452012">84</xref></sup> There has been a great interest in understanding the role of gut microbiota in the instigation and/or perpetuation of inappropriate inflammatory processes in a genetically predisposed host, with several other environmental factors influencing the pathogenesis of IBD. Rising rates of IBD and other autoimmune diseases in Westernized nations underscore the “hygiene hypothesis,” which implicates excessive use of antibiotics and hygiene practices in depriving the gut immune system of the interaction with “essential” microbes that modulate the evolution of our immune system.<sup><xref ref-type="bibr" rid="bibr85-0884533612452012">85</xref></sup> The gut microbial composition of patients with IBD was noted to be abnormal with a decreased prevalence of <italic>Firmicutes</italic>, and specifically butyrate producers such as <italic>Clostridium</italic> IXa and IV groups and <italic>Bifidobacteria</italic>, and a proportionate increase in bacteria such as sulfate-reducing bacteria and <italic>E coli</italic>.<sup><xref ref-type="bibr" rid="bibr86-0884533612452012">86</xref></sup> Roediger et al<sup><xref ref-type="bibr" rid="bibr87-0884533612452012">87</xref></sup> first demonstrated the association between SRB overgrowth and acute ulcerative colitis. This might be explained by the metabolite of SRBs, hydrogen sulfide, which has been shown to produce mucosal inflammation and has genotoxic properties, suggesting SRBs may also play a role in colon cancer.<sup><xref ref-type="bibr" rid="bibr59-0884533612452012">59</xref></sup></p>
</sec>
<sec id="section6-0884533612452012">
<title>Allergy</title>
<p>Associations between allergic disease and altered fecal microbiota, antibiotic use, and dietary factors have been well documented.<sup><xref ref-type="bibr" rid="bibr88-0884533612452012">88</xref></sup> The immunomodulatory effects of intestinal microbiota are essential for immunotolerance through expansion of regulatory T-cell and immunosuppressive cytokines.<sup><xref ref-type="bibr" rid="bibr89-0884533612452012">89</xref></sup> Dysregulation of this complex process results in unwanted immune response toward harmless antigenic stimuli resulting in allergic diseases. Studies of the microbiota in patients with allergies have shown decreased intestinal <italic>Bifidobacteria</italic> counts, an increased prevalence of <italic>B fragilis</italic>, and higher counts of <italic>Staphylococcus aureus</italic> and <italic>E coli</italic>.<sup><xref ref-type="bibr" rid="bibr90-0884533612452012">90</xref>,<xref ref-type="bibr" rid="bibr91-0884533612452012">91</xref></sup></p>
</sec>
<sec id="section7-0884533612452012">
<title>Irritable Bowel Syndrome</title>
<p>Recent studies analyzing the microbiome of patients with IBS in comparison with healthy counterparts identified specific microbial signatures suggesting their role in IBS pathophysiology. In a pediatric study, the microbiome of 7- to 12-year-old patients with IBS was characterized by a significantly greater percentage of the class γ-proteobacteria, such as <italic>Haemophilus parainfluenzae</italic>. In addition, IBS was strongly associated with a specific novel <italic>Ruminococcus</italic>-like microbe, and pain symptoms were related to the presence of genus <italic>Alistipes</italic>.<sup><xref ref-type="bibr" rid="bibr92-0884533612452012">92</xref></sup> In another study analyzing microbiome of adults with IBS, the intestinal microbiota differed significantly from that of controls with a 2-fold increased ratio of <italic>Firmicutes</italic> to <italic>Bacteroidetes</italic>.<sup><xref ref-type="bibr" rid="bibr93-0884533612452012">93</xref></sup> An increase in numbers of <italic>Dorea, Ruminococcus</italic>, and <italic>Clostridium</italic> species; a decrease in the number of <italic>Bacteroidetes, Bifidobacterium</italic>, and <italic>Faecalibacterium</italic> species; and a lower average number of methanogens were identified. Correlation analysis of the microbial groups and IBS symptom scores indicated the involvement of several groups of <italic>Firmicutes</italic> and <italic>Proteobacteria</italic> in the pathogenesis of IBS. Recent experimental and clinical studies suggest that small intestinal bacterial overgrowth, low-grade inflammation, altered gut microbiota, and a dysregulated gut immune system play an important role in the pathogenesis of IBS in addition to a disturbed intestinal motility and gut-brain axis.<sup><xref ref-type="bibr" rid="bibr94-0884533612452012">94</xref></sup></p>
</sec>
<sec id="section8-0884533612452012">
<title>Obesity, Insulin Resistance, and Metabolic Syndrome</title>
<p>The effect of microbiota on obesity as a causative or modulating entity is the focus of several research studies with evidence mostly from studies in mice. Obese mice (ob/ob, with leptin gene mutation) were found to have 50% more <italic>Firmicutes</italic> and a proportionate decrease in <italic>Bacteroidetes</italic> in their gut microbiome when compared with lean (ob/+ and +/+) mice.<sup><xref ref-type="bibr" rid="bibr95-0884533612452012">95</xref></sup> This was associated with increased concentrations of cecal SCFAs, suggesting increased gut microbiotal fermentation and as such an improved energy harvest from the diet.<sup><xref ref-type="bibr" rid="bibr96-0884533612452012">96</xref></sup> Turnbaugh et al<sup><xref ref-type="bibr" rid="bibr97-0884533612452012">97</xref></sup> fed a Western diet to mice and noted a spike in the <italic>Mollicutes</italic> class of <italic>Firmicutes</italic>, which was reversed after dietary modification to limit weight gain. Interestingly enough, when the cecal contents of the obese or lean mice were introduced into the small intestine of the lean germ-free mice and equivalent food intakes were provided, there was a greater increase in body fat in the mice that received microbes from obese donors than in those that received the intestinal contents of lean donors.<sup><xref ref-type="bibr" rid="bibr97-0884533612452012">97</xref></sup></p>
<p>Evidence from human studies has been conflicting so far. Ley et al<sup><xref ref-type="bibr" rid="bibr98-0884533612452012">98</xref></sup> noted an increase in the ratio of <italic>Firmicutes/ Bacteroidetes</italic> in obese individuals when compared with their leaner counterparts and even demonstrated a reverse shift in the gut microbiome toward an increase in the <italic>Bacteroidetes</italic> proportion reflecting that of lean individuals. However, although some researchers replicated these results, others noted contradictory findings of increased Bacteroidetes/ <italic>Firmicutes</italic> ratios.<sup><xref ref-type="bibr" rid="bibr99-0884533612452012">99</xref></sup> Differences in the study diets (eg, restriction of fat or carbohydrate in the study by Ley et al) could be one of the several other confounding factors that drive these shifts, and this area of research merits further investigation.</p>
<p>Recent experimental studies suggest that the microbiota also influence body homeostasis and energy balance via a complex network of actions mediated by microbial metabolites (eg, SCFAs and bile acids), gut innate immunity, and the gut neuroendocrine system.<sup><xref ref-type="bibr" rid="bibr100-0884533612452012">100</xref></sup> Key features include the ability of microbiota to suppress enterocyte expression of angiopoietin-like protein 4 (Angpt14), an inhibitor of lipoprotein lipase (LPL), which promotes triglyceride storage in adipose tissue. In addition, SCFAs bind to G-protein–coupled receptors on neuroendocrine L cells in the ileum to release pancreatic peptide YY (PYY), which in turn increases energy harvest and lipogenesis.</p>
<p>Cani et al<sup><xref ref-type="bibr" rid="bibr101-0884533612452012">101</xref></sup> have shown that a high-fat diet in mice resulted in higher plasma levels of lipopolysaccharide (LPS), a component of gram-negative bacteria cell walls, correlating with an increase in their numbers, which were reversed on treatment with an antibiotic. The state of metabolic endotoxemia from higher LPS levels, considered the consequence of increased gut permeability mediated by the gut microbiota, has been proposed to be responsible for chronic low-grade inflammatory states such as diabetes, alcoholic liver disease, nonalcoholic fatty liver disease (NAFLD), and metabolic syndrome.<sup><xref ref-type="bibr" rid="bibr101-0884533612452012">101</xref>,<xref ref-type="bibr" rid="bibr102-0884533612452012">102</xref></sup> Small intestinal overgrowth of gram-negative organisms also increases endogenous ethanol production and induces choline deficiency, contributing to NAFLD.<sup><xref ref-type="bibr" rid="bibr102-0884533612452012">102</xref></sup></p>
</sec>
<sec id="section9-0884533612452012">
<title>Hepatobiliary Disease</title>
<p>Dysbiosis is implicated in the susceptibility to alcoholic liver disease. A specific pattern of microbiota has been identified in high-risk heavy drinkers, and colonic microbiota composition is affected by daily alcohol consumption. These findings highlight dysbiosis as an important underlying mechanism of alcohol-induced endotoxemia.<sup><xref ref-type="bibr" rid="bibr103-0884533612452012">103</xref></sup> Cultures of the lithogenic bile grew bacteria belonging to <italic>Enterobacteriaceae, Enterococcus</italic>, and <italic>Streptococcus</italic>, indicating a breach in intestinal permeability and a resultant inflammatory response.<sup><xref ref-type="bibr" rid="bibr104-0884533612452012">104</xref></sup> A small study identified bacterial isolates in the bile of only subjects with pigment stones and none from that of healthy subjects, suggesting the association and potential role of gut microbiota in initiating lithogenesis.<sup><xref ref-type="bibr" rid="bibr105-0884533612452012">105</xref></sup> Bacterial analysis of fecal material in cirrhotic patients revealed reduced numbers of beneficial <italic>Bifidobacteria</italic>.<sup><xref ref-type="bibr" rid="bibr106-0884533612452012">106</xref></sup> Administration of probiotics resulted in lower endotoxin levels, fecal pH, and systemic and fecal ammonia corresponding to higher <italic>Bifidobacteria</italic> levels in the stool. In another placebo-controlled study conducted in cirrhotic patients with minimal hepatic encephalopathy (MHE), giving synbiotics (probiotic plus fermentable fiber) or fermentable fiber alone resulted in reversal of MHE and improvement in ammonia levels in 50% of the study patients. The mental status of those who did better was associated with significantly increased fecal content of non-urease-producing <italic>Lactobacillus</italic> species and decreased endotoxin levels.<sup><xref ref-type="bibr" rid="bibr107-0884533612452012">107</xref></sup></p>
</sec>
<sec id="section10-0884533612452012">
<title>The Microbe-Gut-Brain Axis</title>
<p>The impact of the resident microbiota on general body health is probably far more profound than currently recognized, as recent studies have shown that cardiovascular functional impairments, dysregulation of the hypothalamic-pituitary-adrenal axis, and decreased perception of inflammatory pain were noted in GF mice.<sup><xref ref-type="bibr" rid="bibr108-0884533612452012">108</xref></sup> The gastrointestinal system communicates with the brain via complex bidirectional signaling pathways regulated at neural, hormonal, and immunological levels, forming a microbe-gut-brain axis.<sup><xref ref-type="bibr" rid="bibr109-0884533612452012">109</xref></sup> In a study investigating the basal behavior of GF mice and conventional mice in a maze, Neufeld et al<sup><xref ref-type="bibr" rid="bibr110-0884533612452012">110</xref></sup> noted that GF mice exhibited less anxious behavior accompanied by decreased mRNA expression of genes implicated in stress-reactivity and anxiety, highlighting the significance of microbiota on the development of behavior. Ongoing research is now focused on unraveling the influence of the microbiota on the gut-brain axis to facilitate new treatment methods for behavioral and functional bowel disorders by modulation of microbiotal composition.</p>
</sec>
<sec id="section11-0884533612452012">
<title>Future Directions</title>
<list id="list1-0884533612452012" list-type="order">
<list-item><p><italic>General considerations</italic>: It is clear that we were designed to eat a normal balanced diet. A normal balanced diet will support a normal balanced microbiota, which will maintain colonic health and prevent disease, not only in the colon but also in the body.</p></list-item>
<list-item><p><italic>Personalized medicine</italic>: Although a balanced diet will be the most effective approach, there is considerable individual variation in microbiota composition. This is probably explained by the influence of the host on microbial colonization. Thus, the way forward will involve testing microbial composition and their metabolite profiles to determine inflammatory potential in individuals. Specific dietary supplementation, or the use of probiotic species, may then be employed to change the metabolic profile to a noninflammatory one.</p></list-item>
</list>
</sec>
<sec id="section12-0884533612452012">
<title>Summary</title>
<p>Our gastrointestinal tract, especially the colon, is inhabited by trillions of microbes that participate in innumerable metabolic, immunomodulatory, structural, and energy homeostatic functions, making colonic microbiota a vital metabolic organ in its own right. A disturbed composition of the colonic microbiome and internal milieu, as seen in dysbiosis, partners with dietary, genetic, and environmental factors in mediating many diseases in the susceptible host. Advanced techniques have made the challenging task of identifying and characterizing microbes and the microbiome feasible. Equally advanced mathematical and computer-assisted programs will need to be developed to interpret this wealth of new data. Exploration of the details of the host-microbial interactions and elucidation of the involvement of the microbiota in the pathogenesis of a growing list of conditions will expand our understanding of the mechanisms of many human diseases. Manipulation of the microbiota and their metabolites to enhance their beneficial effects on the colon and body health provides an exciting new approach to the management of human disease.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p>Financial disclosure: none declared.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0884533612452012">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>O’Hara</surname><given-names>AM</given-names></name>
<name><surname>Shanahan</surname><given-names>F</given-names></name>
</person-group>. <article-title>The gut flora as a forgotten organ</article-title>. <source>EMBO Rep</source>. <year>2006</year>;<volume>7</volume>(<issue>7</issue>):<fpage>688</fpage>-<lpage>693</lpage>.</citation>
</ref>
<ref id="bibr2-0884533612452012">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Eckburg</surname><given-names>PB</given-names></name>
<name><surname>Bik</surname><given-names>EM</given-names></name>
<name><surname>Bernstein</surname><given-names>CN</given-names></name><etal/>
</person-group>. <article-title>Diversity of the human intestinal microbial flora</article-title>. <source>Science</source>. <year>2005</year>;<volume>308</volume>(<issue>5728</issue>):<fpage>1635</fpage>-<lpage>1638</lpage>.</citation>
</ref>
<ref id="bibr3-0884533612452012">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ley</surname><given-names>RE</given-names></name>
<name><surname>Peterson</surname><given-names>DA</given-names></name>
<name><surname>Gordon</surname><given-names>JI</given-names></name>
</person-group>. <article-title>Ecological and evolutionary forces shaping microbial diversity in the human intestine</article-title>. <source>Cell</source>. <year>2006</year>;<volume>124</volume>(<issue>4</issue>):<fpage>837</fpage>-<lpage>848</lpage>.</citation>
</ref>
<ref id="bibr4-0884533612452012">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mackie</surname><given-names>RI</given-names></name>
<name><surname>Sghir</surname><given-names>A</given-names></name>
<name><surname>Gaskins</surname><given-names>HR</given-names></name>
</person-group>. <article-title>Developmental microbial ecology of the neonatal gastrointestinal tract</article-title>. <source>Am J Clin Nutr</source>. <year>1999</year>;<volume>69</volume>(<issue>5</issue>):<fpage>1035S</fpage>-<lpage>1045S</lpage>.</citation>
</ref>
<ref id="bibr5-0884533612452012">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Palmer</surname><given-names>C</given-names></name>
<name><surname>Bik</surname><given-names>EM</given-names></name>
<name><surname>DiGiulio</surname><given-names>DB</given-names></name>
<name><surname>Relman</surname><given-names>DA</given-names></name>
<name><surname>Brown</surname><given-names>PO</given-names></name>
</person-group>. <article-title>Development of the human infant intestinal microbiota</article-title>. <source>PLoS Biol</source>. <year>2007</year>;<volume>5</volume>(<issue>7</issue>):<fpage>26</fpage>.</citation>
</ref>
<ref id="bibr6-0884533612452012">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>H</given-names></name>
<name><surname>DiBaise</surname><given-names>JK</given-names></name>
<name><surname>Zuccolo</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>Human gut microbiota in obesity and after gastric bypass</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2009</year>;<volume>106</volume>(<issue>7</issue>):<fpage>2365</fpage>-<lpage>2370</lpage>.</citation>
</ref>
<ref id="bibr7-0884533612452012">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sekirov</surname><given-names>I</given-names></name>
<name><surname>Russell</surname><given-names>SL</given-names></name>
<name><surname>Antunes</surname><given-names>LC</given-names></name>
<name><surname>Finlay</surname><given-names>BB</given-names></name>
</person-group>. <article-title>Gut microbiota in health and disease</article-title>. <source>Physiol Rev</source>. <year>2010</year>;<volume>90</volume>(<issue>3</issue>):<fpage>859</fpage>-<lpage>904</lpage>.</citation>
</ref>
<ref id="bibr8-0884533612452012">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schloss</surname><given-names>PD</given-names></name>
<name><surname>Handelsman</surname><given-names>J</given-names></name>
</person-group>. <article-title>Metagenomics for studying unculturable microorganisms: cutting the Gordian knot</article-title>. <source>Genome Biol</source>. <year>2005</year>;<volume>6</volume>(<issue>8</issue>):<fpage>229</fpage>.</citation>
</ref>
<ref id="bibr9-0884533612452012">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nicholson</surname><given-names>JK</given-names></name>
</person-group>. <article-title>Global systems biology, personalized medicine and molecular epidemiology</article-title>. <source>Mol Syst Biol</source>. <year>2006</year>;<volume>2</volume>:<fpage>52</fpage>.</citation>
</ref>
<ref id="bibr10-0884533612452012">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Qin</surname><given-names>J</given-names></name>
<name><surname>Li</surname><given-names>R</given-names></name>
<name><surname>Raes</surname><given-names>J</given-names></name><etal/>
</person-group>. <article-title>A human gut microbial gene catalogue established by metagenomic sequencing</article-title>. <source>Nature</source>. <year>2010</year>;<volume>464</volume>(<issue>7285</issue>):<fpage>59</fpage>-<lpage>65</lpage>.</citation>
</ref>
<ref id="bibr11-0884533612452012">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wardwell</surname><given-names>LH</given-names></name>
<name><surname>Huttenhower</surname><given-names>C</given-names></name>
<name><surname>Garrett</surname><given-names>WS</given-names></name>
</person-group>. <article-title>Current concepts of the intestinal microbiota and the pathogenesis of infection</article-title>. <source>Curr Infect Dis Rep</source>. <year>2011</year>;<volume>13</volume>(<issue>1</issue>):<fpage>28</fpage>-<lpage>34</lpage>.</citation>
</ref>
<ref id="bibr12-0884533612452012">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>O’Keefe</surname><given-names>SJ</given-names></name>
<name><surname>Ou</surname><given-names>J</given-names></name>
<name><surname>Aufreiter</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Products of the colonic microbiota mediate the effects of diet on colon cancer risk</article-title>. <source>J Nutr</source>. <year>2009</year>;<volume>139</volume>(<issue>11</issue>):<fpage>2044</fpage>-<lpage>2048</lpage>.</citation>
</ref>
<ref id="bibr13-0884533612452012">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>O’Keefe</surname><given-names>SJ</given-names></name>
</person-group>. <article-title>The colon as a metabolic organ</article-title>. <source>S Afr Med J</source>. <year>1994</year>;<volume>84</volume>(<issue>7</issue>):<fpage>376</fpage>-<lpage>377</lpage>.</citation>
</ref>
<ref id="bibr14-0884533612452012">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Drossman</surname><given-names>DA</given-names></name>
</person-group>. <article-title>Presidential address: gastrointestinal illness and the biopsychosocial model</article-title>. <source>Psychosom Med</source>. <year>1998</year>;<volume>60</volume>(<issue>3</issue>):<fpage>258</fpage>-<lpage>267</lpage>.</citation>
</ref>
<ref id="bibr15-0884533612452012">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bailey</surname><given-names>MT</given-names></name>
<name><surname>Dowd</surname><given-names>SE</given-names></name>
<name><surname>Parry</surname><given-names>NM</given-names></name>
<name><surname>Galley</surname><given-names>JD</given-names></name>
<name><surname>Schauer</surname><given-names>DB</given-names></name>
<name><surname>Lyte</surname><given-names>M</given-names></name>
</person-group>. <article-title>Stressor exposure disrupts commensal microbial populations in the intestines and leads to increased colonization by</article-title> <source>Citrobacter rodentium. Infect Immun</source>. <year>2010</year>;<volume>78</volume>(<issue>4</issue>):<fpage>1509</fpage>-<lpage>1519</lpage>.</citation>
</ref>
<ref id="bibr16-0884533612452012">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Manichanh</surname><given-names>C</given-names></name>
<name><surname>Varela</surname><given-names>E</given-names></name>
<name><surname>Martinez</surname><given-names>C</given-names></name><etal/>
</person-group>. <article-title>The gut microbiota predispose to the pathophysiology of acute postradiotherapy diarrhea</article-title>. <source>Am J Gastroenterol</source>. <year>2008</year>;<volume>103</volume>(<issue>7</issue>):<fpage>1754</fpage>-<lpage>1761</lpage>.</citation>
</ref>
<ref id="bibr17-0884533612452012">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname><given-names>JV</given-names></name>
<name><surname>Ashrafian</surname><given-names>H</given-names></name>
<name><surname>Bueter</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk</article-title>. <source>Gut</source>. <year>2011</year>;<volume>60</volume>(<issue>9</issue>):<fpage>1214</fpage>-<lpage>1223</lpage>.</citation>
</ref>
<ref id="bibr18-0884533612452012">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>O’Keefe</surname><given-names>SJ</given-names></name>
<name><surname>Chung</surname><given-names>D</given-names></name>
<name><surname>Mahmoud</surname><given-names>N</given-names></name><etal/>
</person-group>. <article-title>Why do African Americans get more colon cancer than native Africans?</article-title> <source>J Nutr</source>. <year>2007</year>;<volume>137</volume>(<issue>1</issue>)(<supplement>suppl</supplement>): <fpage>175S</fpage>-<lpage>182S</lpage>.</citation>
</ref>
<ref id="bibr19-0884533612452012">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Roberfroid</surname><given-names>MB</given-names></name>
</person-group>. <article-title>Introducing inulin-type fructans</article-title>. <source>Br J Nutr</source>. <year>2005</year>; <volume>93</volume>(<issue>1</issue>):<fpage>S13</fpage>-<lpage>S25</lpage>.</citation>
</ref>
<ref id="bibr20-0884533612452012">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Macfarlane</surname><given-names>S</given-names></name>
<name><surname>Macfarlane</surname><given-names>GT</given-names></name>
</person-group>. <article-title>Regulation of short-chain fatty acid production</article-title>. <source>Proc Nutr Soc</source>. <year>2003</year>;<volume>62</volume>(<issue>1</issue>):<fpage>67</fpage>-<lpage>72</lpage>.</citation>
</ref>
<ref id="bibr21-0884533612452012">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cummings</surname><given-names>JH</given-names></name>
</person-group>. <article-title>Short chain fatty acids in the human colon</article-title>. <source>Gut</source>. <year>1981</year>;<volume>22</volume>(<issue>9</issue>):<fpage>763</fpage>-<lpage>779</lpage>.</citation>
</ref>
<ref id="bibr22-0884533612452012">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ou</surname><given-names>J</given-names></name>
<name><surname>DeLany</surname><given-names>JP</given-names></name>
<name><surname>Zhang</surname><given-names>M</given-names></name>
<name><surname>Sharma</surname><given-names>S</given-names></name>
<name><surname>O’Keefe</surname><given-names>SJ</given-names></name>
</person-group>. <article-title>Association between low colonic short-chain fatty acids and high bile acids in high colon cancer risk populations</article-title>. <source>Nutr Cancer</source>. <year>2012</year>;<volume>64</volume>(<issue>1</issue>):<fpage>34</fpage>-<lpage>40</lpage>.</citation>
</ref>
<ref id="bibr23-0884533612452012">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nordgaard</surname><given-names>I</given-names></name>
<name><surname>Mortensen</surname><given-names>PB</given-names></name>
</person-group>. <article-title>Digestive processes in the human colon</article-title>. <source>Nutrition</source>. <year>1995</year>;<volume>11</volume>(<issue>1</issue>):<fpage>37</fpage>-<lpage>45</lpage>.</citation>
</ref>
<ref id="bibr24-0884533612452012">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Grubben</surname><given-names>MJ</given-names></name>
<name><surname>van den Braak</surname><given-names>CC</given-names></name>
<name><surname>Essenberg</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Effect of resistant starch on potential biomarkers for colonic cancer risk in patients with colonic adenomas: a controlled trial</article-title>. <source>Dig Dis Sci</source>. <year>2001</year>;<volume>46</volume>(<issue>4</issue>):<fpage>750</fpage>-<lpage>756</lpage>.</citation>
</ref>
<ref id="bibr25-0884533612452012">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wargovich</surname><given-names>MJ</given-names></name>
<name><surname>Eng</surname><given-names>VW</given-names></name>
<name><surname>Newmark</surname><given-names>HL</given-names></name>
</person-group>. <article-title>Calcium inhibits the damaging and compensatory proliferative effects of fatty acids on mouse colon epithelium</article-title>. <source>Cancer Lett</source>. <year>1984</year>;<volume>23</volume>(<issue>3</issue>):<fpage>253</fpage>-<lpage>258</lpage>.</citation>
</ref>
<ref id="bibr26-0884533612452012">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Willemsen</surname><given-names>LE</given-names></name>
<name><surname>Koetsier</surname><given-names>MA</given-names></name>
<name><surname>van Deventer</surname><given-names>SJ</given-names></name>
<name><surname>van Tol</surname><given-names>EA</given-names></name>
</person-group>. <article-title>Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts</article-title>. <source>Gut</source>. <year>2003</year>;<volume>52</volume>(<issue>10</issue>):<fpage>1442</fpage>-<lpage>1447</lpage>.</citation>
</ref>
<ref id="bibr27-0884533612452012">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cox</surname><given-names>MA</given-names></name>
<name><surname>Jackson</surname><given-names>J</given-names></name>
<name><surname>Stanton</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines</article-title>. <source>World J Gastroenterol</source>. <year>2009</year>;<volume>15</volume>(<issue>44</issue>):<fpage>5549</fpage>-<lpage>5557</lpage>.</citation>
</ref>
<ref id="bibr28-0884533612452012">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bartholome</surname><given-names>AL</given-names></name>
<name><surname>Albin</surname><given-names>DM</given-names></name>
<name><surname>Baker</surname><given-names>DH</given-names></name>
<name><surname>Holst</surname><given-names>JJ</given-names></name>
<name><surname>Tappenden</surname><given-names>KA</given-names></name>
</person-group>. <article-title>Supplementation of total parenteral nutrition with butyrate acutely increases structural aspects of intestinal adaptation after an 80% jejunoileal resection in neonatal piglets</article-title>. <source>JPEN J Parenter Enteral Nutr</source>. <year>2004</year>;<volume>28</volume>(<issue>4</issue>):<fpage>210</fpage>-<lpage>222</lpage>; <comment>discussion 222-223</comment>.</citation>
</ref>
<ref id="bibr29-0884533612452012">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Louis</surname><given-names>P</given-names></name>
<name><surname>Scott</surname><given-names>KP</given-names></name>
<name><surname>Duncan</surname><given-names>SH</given-names></name>
<name><surname>Flint</surname><given-names>HJ</given-names></name>
</person-group>. <article-title>Understanding the effects of diet on bacterial metabolism in the large intestine</article-title>. <source>J Appl Microbiol</source>. <year>2007</year>;<volume>102</volume>(<issue>5</issue>):<fpage>1197</fpage>-<lpage>1208</lpage>.</citation>
</ref>
<ref id="bibr30-0884533612452012">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Roediger</surname><given-names>WE</given-names></name>
</person-group>. <article-title>Utilization of nutrients by isolated epithelial cells of the rat colon</article-title>. <source>Gastroenterology</source>. <year>1982</year>;<volume>83</volume>(<issue>2</issue>):<fpage>424</fpage>-<lpage>429</lpage>.</citation>
</ref>
<ref id="bibr31-0884533612452012">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Watson</surname><given-names>AJ</given-names></name>
</person-group>. <article-title>An overview of apoptosis and the prevention of colorectal cancer</article-title>. <source>Crit Rev Oncol Hematol</source>. <year>2006</year>;<volume>57</volume>(<issue>2</issue>):<fpage>107</fpage>-<lpage>121</lpage>.</citation>
</ref>
<ref id="bibr32-0884533612452012">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rodriguez-Cabezas</surname><given-names>ME</given-names></name>
<name><surname>Galvez</surname><given-names>J</given-names></name>
<name><surname>Lorente</surname><given-names>MD</given-names></name><etal/>
</person-group>. <article-title>Dietary fiber down-regulates colonic tumor necrosis factor alpha and nitric oxide production in trinitrobenzenesulfonic acid–induced colitic rats</article-title>. <source>J Nutr</source>. <year>2002</year>;<volume>132</volume>(<issue>11</issue>):<fpage>3263</fpage>-<lpage>3271</lpage>.</citation>
</ref>
<ref id="bibr33-0884533612452012">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>KA</given-names></name>
<name><surname>Cao</surname><given-names>Y</given-names></name>
<name><surname>Chen</surname><given-names>JR</given-names></name>
<name><surname>Townsend</surname><given-names>CM</given-names><suffix>Jr</suffix></name>
<name><surname>Ko</surname><given-names>TC</given-names></name>
</person-group>. <article-title>Dietary fiber enhances a tumor suppressor signaling pathway in the gut</article-title>. <source>Ann Surg</source>. <year>2006</year>;<volume>243</volume>(<issue>5</issue>):<fpage>619</fpage>-<lpage>625</lpage>.</citation>
</ref>
<ref id="bibr34-0884533612452012">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>YS</given-names></name>
<name><surname>Milner</surname><given-names>JA</given-names></name>
</person-group>. <article-title>Dietary modulation of colon cancer risk</article-title>. <source>J Nutr</source>. <year>2007</year>;<volume>137</volume>(<issue>11</issue>)(<supplement>suppl</supplement>):<fpage>2576S</fpage>-<lpage>2579S</lpage>.</citation>
</ref>
<ref id="bibr35-0884533612452012">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pryde</surname><given-names>SE</given-names></name>
<name><surname>Duncan</surname><given-names>SH</given-names></name>
<name><surname>Hold</surname><given-names>GL</given-names></name>
<name><surname>Stewart</surname><given-names>CS</given-names></name>
<name><surname>Flint</surname><given-names>HJ</given-names></name>
</person-group>. <article-title>The microbiology of butyrate formation in the human colon</article-title>. <source>FEMS Microbiol Lett</source>. <year>2002</year>;<volume>217</volume>(<issue>2</issue>):<fpage>133</fpage>-<lpage>139</lpage>.</citation>
</ref>
<ref id="bibr36-0884533612452012">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Davie</surname><given-names>JR</given-names></name>
</person-group>. <article-title>Inhibition of histone deacetylase activity by butyrate</article-title>. <source>J Nutr</source>. <year>2003</year>;<volume>133</volume>(<issue>7</issue>)(<supplement>suppl</supplement>):<fpage>2485S</fpage>-<lpage>2493S</lpage>.</citation>
</ref>
<ref id="bibr37-0884533612452012">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Greer</surname><given-names>JB</given-names></name>
<name><surname>O’Keefe</surname><given-names>SJ</given-names></name>
</person-group>. <article-title>Microbial induction of immunity, inflammation, and cancer</article-title>. <source>Front Physiol</source>. <year>2011</year>;<volume>1</volume>:<fpage>168</fpage>.</citation>
</ref>
<ref id="bibr38-0884533612452012">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ebert</surname><given-names>MN</given-names></name>
<name><surname>Klinder</surname><given-names>A</given-names></name>
<name><surname>Peters</surname><given-names>WH</given-names></name><etal/>
</person-group>. <article-title>Expression of glutathione S-transferases (GSTs) in human colon cells and inducibility of GSTM2 by butyrate</article-title>. <source>Carcinogenesis</source>. <year>2003</year>;<volume>24</volume>(<issue>10</issue>):<fpage>1637</fpage>-<lpage>1644</lpage>.</citation>
</ref>
<ref id="bibr39-0884533612452012">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Andoh</surname><given-names>A</given-names></name>
<name><surname>Shimada</surname><given-names>M</given-names></name>
<name><surname>Araki</surname><given-names>Y</given-names></name>
<name><surname>Fujiyama</surname><given-names>Y</given-names></name>
<name><surname>Bamba</surname><given-names>T</given-names></name>
</person-group>. <article-title>Sodium butyrate enhances complement-mediated cell injury via down-regulation of decay-accelerating factor expression in colonic cancer cells</article-title>. <source>Cancer Immunol Immunother</source>. <year>2002</year>;<volume>50</volume>(<issue>12</issue>):<fpage>663</fpage>-<lpage>672</lpage>.</citation>
</ref>
<ref id="bibr40-0884533612452012">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zgouras</surname><given-names>D</given-names></name>
<name><surname>Wachtershauser</surname><given-names>A</given-names></name>
<name><surname>Frings</surname><given-names>D</given-names></name>
<name><surname>Stein</surname><given-names>J</given-names></name>
</person-group>. <article-title>Butyrate impairs intestinal tumor cell–induced angiogenesis by inhibiting HIF-1alpha nuclear translocation</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2003</year>;<volume>300</volume>(<issue>4</issue>):<fpage>832</fpage>-<lpage>838</lpage>.</citation>
</ref>
<ref id="bibr41-0884533612452012">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Piche</surname><given-names>T</given-names></name>
<name><surname>des Varannes</surname><given-names>SB</given-names></name>
<name><surname>Sacher-Huvelin</surname><given-names>S</given-names></name>
<name><surname>Holst</surname><given-names>JJ</given-names></name>
<name><surname>Cuber</surname><given-names>JC</given-names></name>
<name><surname>Galmiche</surname><given-names>JP</given-names></name>
</person-group>. <article-title>Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease</article-title>. <source>Gastroenterology</source>. <year>2003</year>;<volume>124</volume>(<issue>4</issue>): <fpage>894</fpage>-<lpage>902</lpage>.</citation>
</ref>
<ref id="bibr42-0884533612452012">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>J</given-names></name>
<name><surname>Hegsted</surname><given-names>M</given-names></name>
<name><surname>McCutcheon</surname><given-names>KL</given-names></name><etal/>
</person-group>. <article-title>Peptide YY and proglucagon mRNA expression patterns and regulation in the gut</article-title>. <source>Obesity (Silver Spring)</source>. <year>2006</year>;<volume>14</volume>(<issue>4</issue>):<fpage>683</fpage>-<lpage>689</lpage>.</citation>
</ref>
<ref id="bibr43-0884533612452012">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kien</surname><given-names>CL</given-names></name>
<name><surname>Kepner</surname><given-names>J</given-names></name>
<name><surname>Grotjohn</surname><given-names>K</given-names></name>
<name><surname>Ault</surname><given-names>K</given-names></name>
<name><surname>McClead</surname><given-names>RE</given-names></name>
</person-group>. <article-title>Stable isotope model for estimating colonic acetate production in premature infants</article-title>. <source>Gastroenterology</source>. <year>1992</year>;<volume>102</volume>(<issue>5</issue>):<fpage>1458</fpage>-<lpage>1466</lpage>.</citation>
</ref>
<ref id="bibr44-0884533612452012">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Puchowicz</surname><given-names>MA</given-names></name>
<name><surname>Bederman</surname><given-names>IR</given-names></name>
<name><surname>Comte</surname><given-names>B</given-names></name><etal/>
</person-group>. <article-title>Zonation of acetate labeling across the liver: implications for studies of lipogenesis by MIDA</article-title>. <source>Am J Physiol</source>. <year>1999</year>;<volume>277</volume>(6, pt 1):<fpage>E1022</fpage>-<lpage>E1027</lpage>.</citation>
</ref>
<ref id="bibr45-0884533612452012">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Venter</surname><given-names>CS</given-names></name>
<name><surname>Vorster</surname><given-names>HH</given-names></name>
<name><surname>Cummings</surname><given-names>JH</given-names></name>
</person-group>. <article-title>Effects of dietary propionate on carbohydrate and lipid metabolism in healthy volunteers</article-title>. <source>Am J Gastroenterol</source>. <year>1990</year>;<volume>85</volume>(<issue>5</issue>):<fpage>549</fpage>-<lpage>553</lpage>.</citation>
</ref>
<ref id="bibr46-0884533612452012">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rodwell</surname><given-names>VW</given-names></name>
<name><surname>Nordstrom</surname><given-names>JL</given-names></name>
<name><surname>Mitschelen</surname><given-names>JJ</given-names></name>
</person-group>. <article-title>Regulation of HMG-CoA reductase</article-title>. <source>Adv Lipid Res</source>. <year>1976</year>;<volume>14</volume>:<fpage>1</fpage>-<lpage>74</lpage>.</citation>
</ref>
<ref id="bibr47-0884533612452012">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Al-Lahham</surname><given-names>SH</given-names></name>
<name><surname>Peppelenbosch</surname><given-names>MP</given-names></name>
<name><surname>Roelofsen</surname><given-names>H</given-names></name>
<name><surname>Vonk</surname><given-names>RJ</given-names></name>
<name><surname>Venema</surname><given-names>K</given-names></name>
</person-group>. <article-title>Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms</article-title>. <source>Biochim Biophys Acta</source>. <year>2010</year>;<volume>1801</volume>(<issue>11</issue>):<fpage>1175</fpage>-<lpage>1183</lpage>.</citation>
</ref>
<ref id="bibr48-0884533612452012">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dannhardt</surname><given-names>G</given-names></name>
<name><surname>Lehr</surname><given-names>M</given-names></name>
</person-group>. <article-title>Nonsteroidal antiinflammatory agents, XVII: inhibition of bovine cyclooxygenase and 5-lipoxygenase by N-alkyldiphenyl-pyrrolyl acetic and propionic acid derivatives</article-title>. <source>Arch Pharm (Weinheim)</source>. <year>1993</year>;<volume>326</volume>(<issue>3</issue>):<fpage>157</fpage>-<lpage>162</lpage>.</citation>
</ref>
<ref id="bibr49-0884533612452012">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zapolska-Downar</surname><given-names>D</given-names></name>
<name><surname>Naruszewicz</surname><given-names>M</given-names></name>
</person-group>. <article-title>Propionate reduces the cytokine-induced VCAM-1 and ICAM-1 expression by inhibiting nuclear factor-kappa B (NF-kappaB) activation</article-title>. <source>J Physiol Pharmacol</source>. <year>2009</year>; <volume>60</volume>(<issue>2</issue>):<fpage>123</fpage>-<lpage>131</lpage>.</citation>
</ref>
<ref id="bibr50-0884533612452012">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lawhon</surname><given-names>SD</given-names></name>
<name><surname>Maurer</surname><given-names>R</given-names></name>
<name><surname>Suyemoto</surname><given-names>M</given-names></name>
<name><surname>Altier</surname><given-names>C</given-names></name>
</person-group>. <article-title>Intestinal short-chain fatty acids alter <italic>Salmonella typhimurium</italic> invasion gene expression and virulence through BarA/SirA</article-title>. <source>Mol Microbiol</source>. <year>2002</year>;<volume>46</volume>(<issue>5</issue>):<fpage>1451</fpage>-<lpage>1464</lpage>.</citation>
</ref>
<ref id="bibr51-0884533612452012">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ruijschop</surname><given-names>RMAJ</given-names></name>
<name><surname>Boelrijk</surname><given-names>AEM</given-names></name>
<name><surname>te Giffela</surname><given-names>MC</given-names></name>
</person-group>. <article-title>Satiety effects of a dairy beverage fermented with propionic acid bacteria</article-title>. <source>Int Dairy J</source>. <year>2008</year>;<volume>18</volume>: <fpage>945</fpage>-<lpage>950</lpage>.</citation>
</ref>
<ref id="bibr52-0884533612452012">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Al-Lahham</surname><given-names>SH</given-names></name>
<name><surname>Roelofsen</surname><given-names>H</given-names></name>
<name><surname>Priebe</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Regulation of adipokine production in human adipose tissue by propionic acid</article-title>. <source>Eur J Clin Invest</source>. <year>2010</year>;<volume>40</volume>(<issue>5</issue>):<fpage>401</fpage>-<lpage>407</lpage>.</citation>
</ref>
<ref id="bibr53-0884533612452012">
<label>53.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cebra</surname><given-names>JJ</given-names></name>
<name><surname>Periwal</surname><given-names>SB</given-names></name>
<name><surname>Lee</surname><given-names>G</given-names></name>
<name><surname>Lee</surname><given-names>F</given-names></name>
<name><surname>Shroff</surname><given-names>KE</given-names></name>
</person-group>. <article-title>Development and maintenance of the gut-associated lymphoid tissue (GALT): the roles of enteric bacteria and viruses</article-title>. <source>Dev Immunol</source>. <year>1998</year>;<volume>6</volume>(<issue>1-2</issue>):<fpage>13</fpage>-<lpage>18</lpage>.</citation>
</ref>
<ref id="bibr54-0884533612452012">
<label>54.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wells</surname><given-names>JM</given-names></name>
<name><surname>Rossi</surname><given-names>O</given-names></name>
<name><surname>Meijerink</surname><given-names>M</given-names></name>
<name><surname>van Baarlen</surname><given-names>P</given-names></name>
</person-group>. <article-title>Epithelial crosstalk at the microbiota-mucosal interface</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2011</year>;<volume>108</volume>(<issue>suppl 1</issue>):<fpage>4607</fpage>-<lpage>4614</lpage>.</citation>
</ref>
<ref id="bibr55-0884533612452012">
<label>55.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Abreu</surname><given-names>MT</given-names></name>
</person-group>. <article-title>Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function</article-title>. <source>Nat Rev Immunol</source>. <year>2010</year>;<volume>10</volume>(<issue>2</issue>):<fpage>131</fpage>-<lpage>144</lpage>.</citation>
</ref>
<ref id="bibr56-0884533612452012">
<label>56.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wells</surname><given-names>JM</given-names></name>
<name><surname>Rossi</surname><given-names>O</given-names></name>
<name><surname>Meijerink</surname><given-names>M</given-names></name>
<name><surname>van Baarlen</surname><given-names>P</given-names></name>
</person-group>. <article-title>Epithelial crosstalk at the microbiota-mucosal interface</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2011</year>;<volume>1</volume>:<fpage>4607</fpage>-<lpage>4614</lpage>.</citation>
</ref>
<ref id="bibr57-0884533612452012">
<label>57.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>O’Keefe</surname><given-names>SJ</given-names></name>
</person-group>. <article-title>Nutrition and colonic health: the critical role of the microbiota</article-title>. <source>Curr Opin Gastroenterol</source>. <year>2008</year>;<volume>24</volume>(<issue>1</issue>):<fpage>51</fpage>-<lpage>58</lpage>.</citation>
</ref>
<ref id="bibr58-0884533612452012">
<label>58.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gibson</surname><given-names>GR</given-names></name>
<name><surname>Cummings</surname><given-names>JH</given-names></name>
<name><surname>Macfarlane</surname><given-names>GT</given-names></name>
</person-group>. <article-title>Competition for hydrogen between sulphate-reducing bacteria and methanogenic bacteria from the human large intestine</article-title>. <source>J Appl Bacteriol</source>. <year>1988</year>;<volume>65</volume>(<issue>3</issue>):<fpage>241</fpage>-<lpage>247</lpage>.</citation>
</ref>
<ref id="bibr59-0884533612452012">
<label>59.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Attene-Ramos</surname><given-names>MS</given-names></name>
<name><surname>Wagner</surname><given-names>ED</given-names></name>
<name><surname>Gaskins</surname><given-names>HR</given-names></name>
<name><surname>Plewa</surname><given-names>MJ</given-names></name>
</person-group>. <article-title>Hydrogen sulfide induces direct radical-associated DNA damage</article-title>. <source>Mol Cancer Res</source>. <year>2007</year>;<volume>5</volume>(<issue>5</issue>):<fpage>455</fpage>-<lpage>459</lpage>.</citation>
</ref>
<ref id="bibr60-0884533612452012">
<label>60.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gibson</surname><given-names>GR</given-names></name>
<name><surname>Macfarlane</surname><given-names>GT</given-names></name>
<name><surname>Cummings</surname><given-names>JH</given-names></name>
</person-group>. <article-title>Sulphate reducing bacteria and hydrogen metabolism in the human large intestine</article-title>. <source>Gut</source>. <year>1993</year>;<volume>34</volume>(<issue>4</issue>):<fpage>437</fpage>-<lpage>439</lpage>.</citation>
</ref>
<ref id="bibr61-0884533612452012">
<label>61.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nagengast</surname><given-names>FM</given-names></name>
<name><surname>Grubben</surname><given-names>MJ</given-names></name>
<name><surname>van Munster</surname><given-names>IP</given-names></name>
</person-group>. <article-title>Role of bile acids in colorectal carcinogenesis</article-title>. <source>Eur J Cancer</source>. <year>1995</year>;<volume>31A</volume>(<issue>7-8</issue>):<fpage>1067</fpage>-<lpage>1070</lpage>.</citation>
</ref>
<ref id="bibr62-0884533612452012">
<label>62.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ridlon</surname><given-names>JM</given-names></name>
<name><surname>Kang</surname><given-names>DJ</given-names></name>
<name><surname>Hylemon</surname><given-names>PB</given-names></name>
</person-group>. <article-title>Bile salt biotransformations by human intestinal bacteria</article-title>. <source>J Lipid Res</source>. <year>2006</year>;<volume>47</volume>(<issue>2</issue>):<fpage>241</fpage>-<lpage>259</lpage>.</citation>
</ref>
<ref id="bibr63-0884533612452012">
<label>63.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cheng</surname><given-names>K</given-names></name>
<name><surname>Raufman</surname><given-names>JP</given-names></name>
</person-group>. <article-title>Bile acid–induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors</article-title>. <source>Biochem Pharmacol</source>. <year>2005</year>;<volume>70</volume>(<issue>7</issue>):<fpage>1035</fpage>-<lpage>1047</lpage>.</citation>
</ref>
<ref id="bibr64-0884533612452012">
<label>64.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Payne</surname><given-names>CM</given-names></name>
<name><surname>Crowley-Skillicorn</surname><given-names>C</given-names></name>
<name><surname>Bernstein</surname><given-names>C</given-names></name>
<name><surname>Holubec</surname><given-names>H</given-names></name>
<name><surname>Moyer</surname><given-names>MP</given-names></name>
<name><surname>Bernstein</surname><given-names>H</given-names></name>
</person-group>. <article-title>Hydrophobic bile acid–induced micronuclei formation, mitotic perturbations, and decreases in spindle checkpoint proteins: relevance to genomic instability in colon carcinogenesis</article-title>. <source>Nutr Cancer</source>. <year>2010</year>;<volume>62</volume>(<issue>6</issue>):<fpage>825</fpage>-<lpage>840</lpage>.</citation>
</ref>
<ref id="bibr65-0884533612452012">
<label>65.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Balamurugan</surname><given-names>R</given-names></name>
<name><surname>Rajendiran</surname><given-names>E</given-names></name>
<name><surname>George</surname><given-names>S</given-names></name>
<name><surname>Samuel</surname><given-names>GV</given-names></name>
<name><surname>Ramakrishna</surname><given-names>BS</given-names></name>
</person-group>. <article-title>Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, <italic>Desulfovibrio</italic> and <italic>Enterococcus faecalis</italic> in the feces of patients with colorectal cancer</article-title>. <source>J Gastroenterol Hepatol</source>. <year>2008</year>;<volume>23</volume>(<issue>8, pt 1</issue>):<fpage>1298</fpage>-<lpage>1303</lpage>.</citation>
</ref>
<ref id="bibr66-0884533612452012">
<label>66.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sobhani</surname><given-names>I</given-names></name>
<name><surname>Tap</surname><given-names>J</given-names></name>
<name><surname>Roudot-Thoraval</surname><given-names>F</given-names></name><etal/>
</person-group>. <article-title>Microbial dysbiosis in colorectal cancer (CRC) patients</article-title>. <source>PLoS One</source>. <year>2011</year>;<volume>6</volume>(<issue>1</issue>):<fpage>e16393</fpage>.</citation>
</ref>
<ref id="bibr67-0884533612452012">
<label>67.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Castellarin</surname><given-names>M</given-names></name>
<name><surname>Warren</surname><given-names>RL</given-names></name>
<name><surname>Freeman</surname><given-names>JD</given-names></name>
<etal/>
</person-group>. <article-title><italic>Fusobacterium nucleatum</italic> infection is prevalent in human colorectal carcinoma</article-title> [<comment>published online ahead of print October 18, 2011</comment>]. <source>Genome Res</source>. doi:10.1101/gr.126516.111<pub-id pub-id-type="doi">10.1101/gr.126516.111</pub-id>.</citation>
</ref>
<ref id="bibr68-0884533612452012">
<label>68.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McLean</surname><given-names>MH</given-names></name>
<name><surname>Murray</surname><given-names>GI</given-names></name>
<name><surname>Stewart</surname><given-names>KN</given-names></name><etal/>
</person-group>. <article-title>The inflammatory microenvironment in colorectal neoplasia</article-title>. <source>PLoS One</source>. <year>2011</year>;<volume>6</volume>(<issue>1</issue>):<fpage>e15366</fpage>.</citation>
</ref>
<ref id="bibr69-0884533612452012">
<label>69.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wu</surname><given-names>S</given-names></name>
<name><surname>Rhee</surname><given-names>KJ</given-names></name>
<name><surname>Albesiano</surname><given-names>E</given-names></name><etal/>
</person-group>. <article-title>A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses</article-title>. <source>Nat Med</source>. <year>2009</year>;<volume>15</volume>(<issue>9</issue>):<fpage>1016</fpage>-<lpage>1022</lpage>.</citation>
</ref>
<ref id="bibr70-0884533612452012">
<label>70.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Abdulamir</surname><given-names>AS</given-names></name>
<name><surname>Hafidh</surname><given-names>RR</given-names></name>
<name><surname>Abu Bakar</surname><given-names>F</given-names></name>
</person-group>. <article-title>The association of <italic>Streptococcus bovis/gallolyticus</italic> with colorectal tumors: the nature and the underlying mechanisms of its etiological role</article-title>. <source>J Exp Clin Cancer Res</source>. <year>2011</year>;<volume>30</volume>:<fpage>11</fpage>.</citation>
</ref>
<ref id="bibr71-0884533612452012">
<label>71.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tsilidis</surname><given-names>KK</given-names></name>
<name><surname>Branchini</surname><given-names>C</given-names></name>
<name><surname>Guallar</surname><given-names>E</given-names></name>
<name><surname>Helzlsouer</surname><given-names>KJ</given-names></name>
<name><surname>Erlinger</surname><given-names>TP</given-names></name>
<name><surname>Platz</surname><given-names>EA</given-names></name>
</person-group>. <article-title>C-reactive protein and colorectal cancer risk: a systematic review of prospective studies</article-title>. <source>Int J Cancer</source>. <year>2008</year>;<volume>123</volume>(<issue>5</issue>):<fpage>1133</fpage>-<lpage>1140</lpage>.</citation>
</ref>
<ref id="bibr72-0884533612452012">
<label>72.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Din</surname><given-names>FV</given-names></name>
<name><surname>Theodoratou</surname><given-names>E</given-names></name>
<name><surname>Farrington</surname><given-names>SM</given-names></name><etal/>
</person-group>. <article-title>Effect of aspirin and NSAIDs on risk and survival from colorectal cancer</article-title>. <source>Gut</source>. <year>2010</year>;<volume>59</volume>(<issue>12</issue>):<fpage>1670</fpage>-<lpage>1679</lpage>.</citation>
</ref>
<ref id="bibr73-0884533612452012">
<label>73.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Swidsinski</surname><given-names>A</given-names></name>
<name><surname>Khilkin</surname><given-names>M</given-names></name>
<name><surname>Kerjaschki</surname><given-names>D</given-names></name><etal/>
</person-group>. <article-title>Association between intraepithelial <italic>Escherichia coli</italic> and colorectal cancer</article-title>. <source>Gastroenterology</source>. <year>1998</year>;<volume>115</volume>(<issue>2</issue>):<fpage>281</fpage>-<lpage>286</lpage>.</citation>
</ref>
<ref id="bibr74-0884533612452012">
<label>74.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Huycke</surname><given-names>MM</given-names></name>
<name><surname>Gaskins</surname><given-names>HR</given-names></name>
</person-group>. <article-title>Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models</article-title>. <source>Exp Biol Med (Maywood)</source>. <year>2004</year>;<volume>229</volume>(<issue>7</issue>):<fpage>586</fpage>-<lpage>597</lpage>.</citation>
</ref>
<ref id="bibr75-0884533612452012">
<label>75.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Onoue</surname><given-names>M</given-names></name>
<name><surname>Kado</surname><given-names>S</given-names></name>
<name><surname>Sakaitani</surname><given-names>Y</given-names></name>
<name><surname>Uchida</surname><given-names>K</given-names></name>
<name><surname>Morotomi</surname><given-names>M</given-names></name>
</person-group>. <article-title>Specific species of intestinal bacteria influence the induction of aberrant crypt foci by 1,2-dimethylhydrazine in rats</article-title>. <source>Cancer Lett</source>. <year>1997</year>;<volume>113</volume>(<issue>1-2</issue>):<fpage>179</fpage>-<lpage>186</lpage>.</citation>
</ref>
<ref id="bibr76-0884533612452012">
<label>76.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>de Vogel</surname><given-names>J</given-names></name>
<name><surname>van-Eck</surname><given-names>WB</given-names></name>
<name><surname>Sesink</surname><given-names>AL</given-names></name>
<name><surname>Jonker-Termont</surname><given-names>DS</given-names></name>
<name><surname>Kleibeuker</surname><given-names>J</given-names></name>
<name><surname>van der Meer</surname><given-names>R</given-names></name>
</person-group>. <article-title>Dietary heme injures surface epithelium resulting in hyperproliferation, inhibition of apoptosis and crypt hyperplasia in rat colon</article-title>. <source>Carcinogenesis</source>. <year>2008</year>;<volume>29</volume>(<issue>2</issue>):<fpage>398</fpage>-<lpage>403</lpage>.</citation>
</ref>
<ref id="bibr77-0884533612452012">
<label>77.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wu</surname><given-names>K</given-names></name>
<name><surname>Giovannucci</surname><given-names>E</given-names></name>
<name><surname>Byrne</surname><given-names>C</given-names></name>
<etal/>
</person-group>. <article-title>Meat mutagens and risk of distal colon adenoma in a cohort of U.S. men</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>. <year>2006</year>;<volume>15</volume>(<issue>6</issue>):<fpage>1120</fpage>-<lpage>1125</lpage>.</citation>
</ref>
<ref id="bibr78-0884533612452012">
<label>78.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McMillan</surname><given-names>L</given-names></name>
<name><surname>Butcher</surname><given-names>S</given-names></name>
<name><surname>Wallis</surname><given-names>Y</given-names></name>
<name><surname>Neoptolemos</surname><given-names>JP</given-names></name>
<name><surname>Lord</surname><given-names>JM</given-names></name>
</person-group>. <article-title>Bile acids reduce the apoptosis-inducing effects of sodium butyrate on human colon adenoma (AA/C1) cells: implications for colon carcinogenesis</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2000</year>;<volume>273</volume>(<issue>1</issue>):<fpage>45</fpage>-<lpage>49</lpage>.</citation>
</ref>
<ref id="bibr79-0884533612452012">
<label>79.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>de Vogel</surname><given-names>J</given-names></name>
<name><surname>Jonker-Termont</surname><given-names>DS</given-names></name>
<name><surname>van Lieshout</surname><given-names>EM</given-names></name>
<name><surname>Katan</surname><given-names>MB</given-names></name>
<name><surname>van der Meer</surname><given-names>R</given-names></name>
</person-group>. <article-title>Green vegetables, red meat and colon cancer: chlorophyll prevents the cytotoxic and hyperproliferative effects of haem in rat colon</article-title>. <source>Carcinogenesis</source>. <year>2005</year>;<volume>26</volume>(<issue>2</issue>):<fpage>387</fpage>-<lpage>393</lpage>.</citation>
</ref>
<ref id="bibr80-0884533612452012">
<label>80.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Toden</surname><given-names>S</given-names></name>
<name><surname>Bird</surname><given-names>AR</given-names></name>
<name><surname>Topping</surname><given-names>DL</given-names></name>
<name><surname>Conlon</surname><given-names>MA</given-names></name>
</person-group>. <article-title>Resistant starch prevents colonic DNA damage induced by high dietary cooked red meat or casein in rats</article-title>. <source>Cancer Biol Ther</source>. <year>2006</year>;<volume>5</volume>(<issue>3</issue>):<fpage>267</fpage>-<lpage>272</lpage>.</citation>
</ref>
<ref id="bibr81-0884533612452012">
<label>81.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Young</surname><given-names>VB</given-names></name>
<name><surname>Schmidt</surname><given-names>TM</given-names></name>
</person-group>. <article-title>Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota</article-title>. <source>J Clin Microbiol</source>. <year>2004</year>;<volume>42</volume>(<issue>3</issue>):<fpage>1203</fpage>-<lpage>1206</lpage>.</citation>
</ref>
<ref id="bibr82-0884533612452012">
<label>82.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Reeves</surname><given-names>AE</given-names></name>
<name><surname>Theriot</surname><given-names>CM</given-names></name>
<name><surname>Bergin</surname><given-names>IL</given-names></name>
<name><surname>Huffnagle</surname><given-names>GB</given-names></name>
<name><surname>Schloss</surname><given-names>PD</given-names></name>
<name><surname>Young</surname><given-names>VB</given-names></name>
</person-group>. <article-title>The interplay between microbiome dynamics and pathogen dynamics in a murine model of <italic>Clostridium difficile</italic> infection</article-title>. <source>Gut Microbes</source>. <year>2011</year>;<volume>2</volume>(<issue>3</issue>):<fpage>145</fpage>-<lpage>158</lpage>.</citation>
</ref>
<ref id="bibr83-0884533612452012">
<label>83.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Khoruts</surname><given-names>A</given-names></name>
<name><surname>Dicksved</surname><given-names>J</given-names></name>
<name><surname>Jansson</surname><given-names>JK</given-names></name>
<name><surname>Sadowsky</surname><given-names>MJ</given-names></name>
</person-group>. <article-title>Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent <italic>Clostridium difficile</italic>–associated diarrhea</article-title>. <source>J Clin Gastroenterol</source>. <year>2010</year>;<volume>44</volume>(<issue>5</issue>):<fpage>354</fpage>-<lpage>360</lpage>.</citation>
</ref>
<ref id="bibr84-0884533612452012">
<label>84.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Loftus</surname><given-names>EV</given-names><suffix>Jr</suffix></name>
</person-group>. <article-title>Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences</article-title>. <source>Gastroenterology</source>. <year>2004</year>;<volume>126</volume>(<issue>6</issue>):<fpage>1504</fpage>-<lpage>1517</lpage>.</citation>
</ref>
<ref id="bibr85-0884533612452012">
<label>85.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Strachan</surname><given-names>DP</given-names></name>
</person-group>. <article-title>Hay fever, hygiene, and household size</article-title>. <source>BMJ</source>. <year>1989</year>; <volume>299</volume>(<issue>6710</issue>):<fpage>1259</fpage>-<lpage>1260</lpage>.</citation>
</ref>
<ref id="bibr86-0884533612452012">
<label>86.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fava</surname><given-names>F</given-names></name>
<name><surname>Danese</surname><given-names>S</given-names></name>
</person-group>. <article-title>Intestinal microbiota in inflammatory bowel disease: friend of foe?</article-title> <source>World J Gastroenterol</source>. <year>2011</year>;<volume>17</volume>(<issue>5</issue>):<fpage>557</fpage>-<lpage>566</lpage>.</citation>
</ref>
<ref id="bibr87-0884533612452012">
<label>87.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Roediger</surname><given-names>WE</given-names></name>
<name><surname>Duncan</surname><given-names>A</given-names></name>
<name><surname>Kapaniris</surname><given-names>O</given-names></name>
<name><surname>Millard</surname><given-names>S</given-names></name>
</person-group>. <article-title>Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis</article-title>. <source>Gastroenterology</source>. <year>1993</year>;<volume>104</volume>(<issue>3</issue>):<fpage>802</fpage>-<lpage>809</lpage>.</citation>
</ref>
<ref id="bibr88-0884533612452012">
<label>88.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>M</given-names></name>
<name><surname>Karlsson</surname><given-names>C</given-names></name>
<name><surname>Olsson</surname><given-names>C</given-names></name><etal/>
</person-group>. <article-title>Reduced diversity in the early fecal microbiota of infants with atopic eczema</article-title>. <source>J Allergy Clin Immunol</source>. <year>2008</year>;<volume>121</volume>(<issue>1</issue>):<fpage>129</fpage>-<lpage>134</lpage>.</citation>
</ref>
<ref id="bibr89-0884533612452012">
<label>89.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McLoughlin</surname><given-names>RM</given-names></name>
<name><surname>Mills</surname><given-names>KH</given-names></name>
</person-group>. <article-title>Influence of gastrointestinal commensal bacteria on the immune responses that mediate allergy and asthma</article-title>. <source>J Allergy Clin Immunol</source>. <year>2011</year>;<volume>127</volume>(<issue>5</issue>):<fpage>1097</fpage>-<lpage>1107</lpage>; <comment>quiz 1108-1109</comment>.</citation>
</ref>
<ref id="bibr90-0884533612452012">
<label>90.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Penders</surname><given-names>J</given-names></name>
<name><surname>Stobberingh</surname><given-names>EE</given-names></name>
<name><surname>van den Brandt</surname><given-names>PA</given-names></name>
<name><surname>Thijs</surname><given-names>C</given-names></name>
</person-group>. <article-title>The role of the intestinal microbiota in the development of atopic disorders</article-title>. <source>Allergy</source>. <year>2007</year>;<volume>62</volume>(<issue>11</issue>):<fpage>1223</fpage>-<lpage>1236</lpage>.</citation>
</ref>
<ref id="bibr91-0884533612452012">
<label>91.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Penders</surname><given-names>J</given-names></name>
<name><surname>Stobberingh</surname><given-names>EE</given-names></name>
<name><surname>Thijs</surname><given-names>C</given-names></name><etal/>
</person-group>. <article-title>Molecular fingerprinting of the intestinal microbiota of infants in whom atopic eczema was or was not developing</article-title>. <source>Clin Exp Allergy</source>. <year>2006</year>;<volume>36</volume>(<issue>12</issue>):<fpage>1602</fpage>-<lpage>1608</lpage>.</citation>
</ref>
<ref id="bibr92-0884533612452012">
<label>92.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Saulnier</surname><given-names>DM</given-names></name>
<name><surname>Riehle</surname><given-names>K</given-names></name>
<name><surname>Mistretta</surname><given-names>TA</given-names></name><etal/>
</person-group>. <article-title>Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome</article-title>. <source>Gastroenterology</source>. <year>2011</year>;<volume>141</volume>(<issue>5</issue>):<fpage>1782</fpage>-<lpage>1791</lpage>.</citation>
</ref>
<ref id="bibr93-0884533612452012">
<label>93.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rajilic-Stojanovic</surname><given-names>M</given-names></name>
<name><surname>Biagi</surname><given-names>E</given-names></name>
<name><surname>Heilig</surname><given-names>HG</given-names></name><etal/>
</person-group>. <article-title>Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome</article-title>. <source>Gastroenterology</source>. <year>2011</year>;<volume>141</volume>(<issue>5</issue>):<fpage>1792</fpage>-<lpage>1801</lpage>.</citation>
</ref>
<ref id="bibr94-0884533612452012">
<label>94.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>BJ</given-names></name>
<name><surname>Bak</surname><given-names>YT</given-names></name>
</person-group>. <article-title>Irritable bowel syndrome, gut microbiota and probiotics</article-title>. <source>J Neurogastroenterol Motil</source>. <year>2011</year>;<volume>17</volume>(<issue>3</issue>):<fpage>252</fpage>-<lpage>266</lpage>.</citation>
</ref>
<ref id="bibr95-0884533612452012">
<label>95.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ley</surname><given-names>RE</given-names></name>
<name><surname>Backhed</surname><given-names>F</given-names></name>
<name><surname>Turnbaugh</surname><given-names>P</given-names></name>
<name><surname>Lozupone</surname><given-names>CA</given-names></name>
<name><surname>Knight</surname><given-names>RD</given-names></name>
<name><surname>Gordon</surname><given-names>JI</given-names></name>
</person-group>. <article-title>Obesity alters gut microbial ecology</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2005</year>;<volume>102</volume>(<issue>31</issue>):<fpage>11070</fpage>-<lpage>11075</lpage>.</citation>
</ref>
<ref id="bibr96-0884533612452012">
<label>96.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Turnbaugh</surname><given-names>PJ</given-names></name>
<name><surname>Ley</surname><given-names>RE</given-names></name>
<name><surname>Mahowald</surname><given-names>MA</given-names></name>
<name><surname>Magrini</surname><given-names>V</given-names></name>
<name><surname>Mardis</surname><given-names>ER</given-names></name>
<name><surname>Gordon</surname><given-names>JI</given-names></name>
</person-group>. <article-title>An obesity-associated gut microbiome with increased capacity for energy harvest</article-title>. <source>Nature</source>. <year>2006</year>;<volume>444</volume>(<issue>7122</issue>):<fpage>1027</fpage>-<lpage>1031</lpage>.</citation>
</ref>
<ref id="bibr97-0884533612452012">
<label>97.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Turnbaugh</surname><given-names>PJ</given-names></name>
<name><surname>Backhed</surname><given-names>F</given-names></name>
<name><surname>Fulton</surname><given-names>L</given-names></name>
<name><surname>Gordon</surname><given-names>JI</given-names></name>
</person-group>. <article-title>Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome</article-title>. <source>Cell Host Microbe</source>. <year>2008</year>;<volume>3</volume>(<issue>4</issue>):<fpage>213</fpage>-<lpage>223</lpage>.</citation>
</ref>
<ref id="bibr98-0884533612452012">
<label>98.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ley</surname><given-names>RE</given-names></name>
<name><surname>Turnbaugh</surname><given-names>PJ</given-names></name>
<name><surname>Klein</surname><given-names>S</given-names></name>
<name><surname>Gordon</surname><given-names>JI</given-names></name>
</person-group>. <article-title>Microbial ecology: human gut microbes associated with obesity</article-title>. <source>Nature</source>. <year>2006</year>;<volume>444</volume>(<issue>7122</issue>):<fpage>1022</fpage>-<lpage>1023</lpage>.</citation>
</ref>
<ref id="bibr99-0884533612452012">
<label>99.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schwiertz</surname><given-names>A</given-names></name>
<name><surname>Taras</surname><given-names>D</given-names></name>
<name><surname>Schafer</surname><given-names>K</given-names></name><etal/>
</person-group>. <article-title>Microbiota and SCFA in lean and overweight healthy subjects</article-title>. <source>Obesity (Silver Spring)</source>. <year>2010</year>;<volume>18</volume>(<issue>1</issue>): <fpage>190</fpage>-<lpage>195</lpage>.</citation>
</ref>
<ref id="bibr100-0884533612452012">
<label>100.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Greiner</surname><given-names>T</given-names></name>
<name><surname>Backhed</surname><given-names>F</given-names></name>
</person-group>. <article-title>Effects of the gut microbiota on obesity and glucose homeostasis</article-title>. <source>Trends Endocrinol Metab</source>. <year>2011</year>;<volume>22</volume>(<issue>4</issue>):<fpage>117</fpage>-<lpage>123</lpage>.</citation>
</ref>
<ref id="bibr101-0884533612452012">
<label>101.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cani</surname><given-names>PD</given-names></name>
<name><surname>Bibiloni</surname><given-names>R</given-names></name>
<name><surname>Knauf</surname><given-names>C</given-names></name><etal/>
</person-group>. <article-title>Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice</article-title>. <source>Diabetes</source>. <year>2008</year>;<volume>57</volume>(<issue>6</issue>):<fpage>1470</fpage>-<lpage>1481</lpage>.</citation>
</ref>
<ref id="bibr102-0884533612452012">
<label>102.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Abu-Shanab</surname><given-names>A</given-names></name>
<name><surname>Quigley</surname><given-names>EM</given-names></name>
</person-group>. <article-title>The role of the gut microbiota in nonalcoholic fatty liver disease</article-title>. <source>Nat Rev Gastroenterol Hepatol</source>. <year>2010</year>;<volume>7</volume>(<issue>12</issue>): <fpage>691</fpage>-<lpage>701</lpage>.</citation>
</ref>
<ref id="bibr103-0884533612452012">
<label>103.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mutlu</surname><given-names>E</given-names></name>
<name><surname>Keshavarzian</surname><given-names>A</given-names></name>
<name><surname>Engen</surname><given-names>P</given-names></name>
<name><surname>Forsyth</surname><given-names>CB</given-names></name>
<name><surname>Sikaroodi</surname><given-names>M</given-names></name>
<name><surname>Gillevet</surname><given-names>P</given-names></name>
</person-group>. <article-title>Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats</article-title>. <source>Alcohol Clin Exp Res</source>. <year>2009</year>;<volume>33</volume>(<issue>10</issue>):<fpage>1836</fpage>-<lpage>1846</lpage>.</citation>
</ref>
<ref id="bibr104-0884533612452012">
<label>104.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Capoor</surname><given-names>MR</given-names></name>
<name><surname>Nair</surname><given-names>D</given-names></name>
<name><surname>Rajni</surname></name>
<etal/>
</person-group>. <article-title>Microflora of bile aspirates in patients with acute cholecystitis with or without cholelithiasis: a tropical experience</article-title>. <source>Braz J Infect Dis</source>. <year>2008</year>;<volume>12</volume>(<issue>3</issue>):<fpage>222</fpage>-<lpage>225</lpage>.</citation>
</ref>
<ref id="bibr105-0884533612452012">
<label>105.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Abeysuriya</surname><given-names>V</given-names></name>
<name><surname>Deen</surname><given-names>KI</given-names></name>
<name><surname>Wijesuriya</surname><given-names>T</given-names></name>
<name><surname>Salgado</surname><given-names>SS</given-names></name>
</person-group>. <article-title>Microbiology of gallbladder bile in uncomplicated symptomatic cholelithiasis</article-title>. <source>Hepatobiliary Pancreat Dis Int</source>. <year>2008</year>;<volume>7</volume>(<issue>6</issue>):<fpage>633</fpage>-<lpage>637</lpage>.</citation>
</ref>
<ref id="bibr106-0884533612452012">
<label>106.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>HY</given-names></name>
<name><surname>Wang</surname><given-names>HJ</given-names></name>
<name><surname>Lu</surname><given-names>Z</given-names></name>
<name><surname>Xu</surname><given-names>SZ</given-names></name>
</person-group>. <article-title>Intestinal microflora in patients with liver cirrhosis</article-title>. <source>Chin J Dig Dis</source>. <year>2004</year>;<volume>5</volume>(<issue>2</issue>):<fpage>64</fpage>-<lpage>67</lpage>.</citation>
</ref>
<ref id="bibr107-0884533612452012">
<label>107.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname><given-names>Q</given-names></name>
<name><surname>Duan</surname><given-names>ZP</given-names></name>
<name><surname>Ha</surname><given-names>DK</given-names></name>
<name><surname>Bengmark</surname><given-names>S</given-names></name>
<name><surname>Kurtovic</surname><given-names>J</given-names></name>
<name><surname>Riordan</surname><given-names>SM</given-names></name>
</person-group>. <article-title>Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis</article-title>. <source>Hepatology</source>. <year>2004</year>;<volume>39</volume>(<issue>5</issue>):<fpage>1441</fpage>-<lpage>1449</lpage>.</citation>
</ref>
<ref id="bibr108-0884533612452012">
<label>108.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sudo</surname><given-names>N</given-names></name>
<name><surname>Chida</surname><given-names>Y</given-names></name>
<name><surname>Aiba</surname><given-names>Y</given-names></name><etal/>
</person-group>. <article-title>Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice</article-title>. <source>J Physiol</source>. <year>2004</year>;<volume>558</volume>(<issue>pt 1</issue>):<fpage>263</fpage>-<lpage>275</lpage>.</citation>
</ref>
<ref id="bibr109-0884533612452012">
<label>109.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cryan</surname><given-names>JF</given-names></name>
<name><surname>O’Mahony</surname><given-names>SM</given-names></name>
</person-group>. <article-title>The microbiome-gut-brain axis: from bowel to behavior</article-title>. <source>Neurogastroenterol Motil</source>. <year>2011</year>;<volume>23</volume>(<issue>3</issue>):<fpage>187</fpage>-<lpage>192</lpage>.</citation>
</ref>
<ref id="bibr110-0884533612452012">
<label>110.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Neufeld</surname><given-names>KM</given-names></name>
<name><surname>Kang</surname><given-names>N</given-names></name>
<name><surname>Bienenstock</surname><given-names>J</given-names></name>
<name><surname>Foster</surname><given-names>JA</given-names></name>
</person-group>. <article-title>Reduced anxiety-like behavior and central neurochemical change in germ-free mice</article-title>. <source>Neurogastroenterol Motil</source>. <year>2011</year>;<volume>23</volume>(<issue>3</issue>):<fpage>255</fpage>-<lpage>264</lpage>, <fpage>e119</fpage>.</citation>
</ref>
</ref-list>
</back>
</article>